National
Coverage Determination (NCD) for Positron Emission Tomography (FDG) for
Oncologic Conditions (220.6.17)
|
Publication Number 100-3 |
Manual Section Number 220.6.17 |
Manual Section Title Positron Emission Tomography (FDG)
for Oncologic Conditions |
|
Version Number 4 |
Effective Date of this Version 6/11/2013 |
Implementation Date 3/7/2014 |
Benefit Category
Diagnostic Tests (other)
Please Note: This may not be an exhaustive list of all
applicable Medicare benefit categories for this item or service.
Item/Service Description
A. General
FDG (2-[F18]
fluoro-2-deoxy-D-glucose) Positron Emission Tomography (PET) is a
minimally-invasive diagnostic imaging procedure used to evaluate glucose
metabolism in normal tissue as well as in diseased tissues in conditions such
as cancer, ischemic heart disease, and some neurologic disorders. FDG is an
injected radionuclide (or radiopharmaceutical) that emits sub-atomic particles,
known as positrons, as it decays. FDG PET uses a positron camera (tomograph) to measure the decay of FDG. The rate of FDG
decay provides biochemical information on glucose metabolism in the tissue
being studied. As malignancies can cause abnormalities of metabolism and blood
flow, FDG PET evaluation may indicate the probable presence or absence of a
malignancy based upon observed differences in biologic activity compared to
adjacent tissues.
The Centers for Medicare
and Medicaid Services (CMS) was asked by the National Oncologic PET Registry
(NOPR) to reconsider section 220.6 of the National Coverage Determinations
(NCD) Manual to end the prospective data collection requirements under Coverage
with Evidence Development (CED) across all oncologic indications of FDG PET
imaging. The CMS received public input indicating that the current coverage
framework of prospective data collection under CED be ended for all oncologic
uses of FDG PET imaging.
1.
Framework
Effective for claims
with dates of service on and after June 11, 2013, CMS is adopting a coverage
framework that ends the prospective data collection requirements by NOPR under
CED for all oncologic uses of FDG PET imaging. CMS is making this change for
all NCDs that address coverage of FDG PET for oncologic uses addressed in this
decision. This decision does not change coverage for any use of PET imaging
using radiopharmaceuticals NaF-18 (fluorine-18 labeled sodium fluoride),
ammonia N-13, or rubidium-82 (Rb-82).
2.
Initial Anti-Tumor Treatment Strategy
CMS continues to believe
that the evidence is adequate to determine that the results of FDG PET imaging
are useful in determining the appropriate initial anti-tumor treatment strategy
for beneficiaries with suspected cancer and improve health outcomes and thus
are reasonable and necessary under §1862(a)(1)(A) of the Social Security Act
(the Act).
Therefore, CMS continues
to nationally cover one FDG PET study for beneficiaries who have cancers that
are biopsy proven or strongly suspected based on other diagnostic testing when
the beneficiary’s treating physician determines that the FDG PET study is
needed to determine the location and/or extent of the tumor for the following
therapeutic purposes related to the initial anti-tumor treatment strategy:
·
To determine whether or
not the beneficiary is an appropriate candidate for an invasive diagnostic or
therapeutic procedure; or
·
To determine the optimal
anatomic location for an invasive procedure; or
·
To determine the
anatomic extent of tumor when the recommended anti-tumor treatment reasonably
depends on the extent of the tumor.
See the table at the end
of this section for a synopsis of all nationally covered and non-covered
oncologic uses of FDG PET imaging.
Indications and Limitations of Coverage
B.1.
Initial Anti-Tumor Treatment Strategy Nationally Covered Indications
a. CMS continues to nationally cover FDG PET
imaging for the initial anti-tumor treatment strategy for male and female
breast cancer only when used in staging distant metastasis.
b. CMS continues to nationally cover FDG PET to
determine initial anti-tumor treatment strategy for melanoma other than for the
evaluation of regional lymph nodes.
c. CMS continues to nationally cover FDG PET
imaging for the detection of pre-treatment metastasis (i.e., staging) in newly
diagnosed cervical cancers following conventional imaging.
C.1
Initial Anti-Tumor Treatment Strategy Nationally Non-Covered Indications
a. CMS continues to nationally non-cover initial
anti-tumor treatment strategy in Medicare beneficiaries who have adenocarcinoma
of the prostate.
b. CMS continues to nationally non-cover FDG PET
imaging for diagnosis of breast cancer and initial staging of axillary nodes.
c. CMS continues to nationally non-cover FDG PET imaging
for initial anti-tumor treatment strategy for the evaluation of regional lymph
nodes in melanoma.
d. CMS continues to nationally non-cover FDG PET
imaging for the diagnosis of cervical cancer related to initial anti-tumor
treatment strategy.
3.
Subsequent Anti-Tumor Treatment Strategy
B.2.
Subsequent Anti-Tumor Treatment Strategy
Nationally Covered Indications
Three FDG PET scans are
nationally covered when used to guide subsequent management of anti-tumor
treatment strategy after completion of initial anti-cancer therapy. Coverage of
more than three FDG PET scans to guide subsequent management of anti-tumor
treatment strategy after completion of initial anti-cancer therapy shall be
determined by the local Medicare Administrative Contractors.
4.
Synopsis of Coverage of FDG PET for Oncologic
Conditions
Effective for claims
with dates of service on and after June 11, 2013, the chart below summarizes
national FDG PET coverage for oncologic conditions:
|
FDG
PET for Cancers |
Initial
Treatment Strategy |
Subsequent
Treatment Strategy (formerly |
|
Colorectal |
Cover |
Cover |
|
Esophagus |
Cover |
Cover |
|
Head and Neck (not thyroid, CNS) |
Cover |
Cover |
|
Lymphoma |
Cover |
Cover |
|
Non-small cell lung |
Cover |
Cover |
|
Ovary |
Cover |
Cover |
|
Brain |
Cover |
Cover |
|
Cervix |
Cover with exceptions * |
Cover |
|
Small cell lung |
Cover |
Cover |
|
Soft tissue sarcoma |
Cover |
Cover |
|
Pancreas |
Cover |
Cover |
|
Testes |
Cover |
Cover |
|
Prostate |
Non-cover |
Cover |
|
Thyroid |
Cover |
Cover |
|
Breast (male and female) |
Cover with exceptions * |
Cover |
|
Melanoma |
Cover with exceptions * |
Cover |
|
All other solid tumors |
Cover |
Cover |
|
Myeloma |
Cover |
Cover |
|
All other cancers not listed |
Cover |
Cover |
*Cervix: Nationally non-covered
for the initial diagnosis of cervical cancer related to initial anti-tumor
treatment strategy. All other indications for initial anti-tumor treatment
strategy for cervical cancer are nationally covered.
*Breast: Nationally non-covered
for initial diagnosis and/or staging of axillary lymph nodes. Nationally
covered for initial staging of metastatic disease. All other indications for
initial anti-tumor treatment strategy for breast cancer are nationally covered.
*Melanoma: Nationally
non-covered for initial staging of regional lymph nodes. All other indications
for initial anti-tumor treatment strategy for melanoma are nationally covered.
D. Other
N/A
Claims Processing
Instructions
·
TN 2873
(Medicare Claims Processing)
·
TN 3911
(Medicare Claims Processing)
Transmittal Number
168
Coverage Transmittal
Link
https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/Downloads/R168NCD.pdf
Revision History
05/2014 - Transmittal
166, dated April 18, 2014, is being rescinded and replaced by Transmittal 168,
dated May 28, 2014 to make a technical correction to delete information in the
Pub. 100-03 NCD manual that should not have been included. All other
information remains the same. (TN 168)
(CR 8739)
04/2014 -
Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) for Solid Tumors
(This CR rescinds and fully replaces CR8468/TR2873 dated February 6, 2014) (TN 166)
(CR 8739)
02/2014 - The purpose of
this Change Request (CR) is effective for claims with dates of service on and
after June 11, 2013, CMS shall cover three FDG PET scans when used to guide
subsequent management of anti-tumor treatment strategy after completion of initial
anti-cancer therapy for the same cancer diagnosis. Coverage of any additional
FDG PET scans (that is, beyond three) used to guide subsequent management of
anti-tumor treatment strategy after completion of initial anti-cancer therapy
for the same diagnosis will be determined by the local Medicare Administrative
Contractors. Effective date 06/11/2013 Implementation date 03/07/2014 (TN 162)
(CR 8468)
09/2010 - On August 4,
2010, CMS issued a final decision that determined the current absolute
restriction of one PET scan for therapeutic purposes associated with the
initial treatment strategy for suspected solid tumors and myeloma is not
supported by available evidence. CMS will amend 220.6.17 of the National
Coverage Determinations (NCD) Manual to remove the restriction of only one FDG
PET scan to determine the location and/or extent of the tumor for therapeutic
purposes related to initial treatment strategy and allow local Medicare
contractors discretion to cover (or not cover) within their jurisdictions any
additional FDG PET scans for therapeutic purposes related to initial treatment
strategy. Effective date 08/04/2010 Implementation date 10/25/2010 (TN 124)
(CR 7148)
12/2009 - Effective for
claims with dates of service on and after November 10, 2009, CMS will end the
coverage with evidence development requirements for FDG PET for cervical cancer
and will cover only one FDG PET for cervical cancer for staging in
beneficiaries with biopsy-proven tumors when the treating physician determines
that the study is needed to determine the location and/or extent of the tumor
for specific therapeutic purposes related to initial treatment strategy.
10/2009 - This change
request rescinds and replaces Transmittal 106, dated September 18, 2009. The
effective date has been changed to April 3, 2009 and the implementation date
has been changed to October 30, 2009. Business Requirements (BR) 6632.6.1 and
6632.6.2 have been revised to clarify that they are subsets of BR 6632.6 and
are specific to CED. All other information remains the same.
09/2009: CMS is adopting
a coverage framework that replaces the four-part diagnosis, staging, restaging
and monitoring response to treatment categories with a two-part framework that
differentiates FDG PET imaging used to inform the initial antitumor treatment
strategy from other uses related to guiding subsequent antitumor treatment
strategies after the completion of initial treatment. CMS is making this change
for all NCDs that address coverage of FDG PET for all oncologic conditions.
Effective date 04/06/2009 Implementation date 10/19/2009 (TN 106)
(CR 6632)
08/2016 - This change
request (CR) is the 9th maintenance update of ICD-10 conversions and other
coding updates specific to national coverage determinations (NCDs). The majority
of the NCDs included are a result of feedback received from previous ICD-10 NCD
CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, and CR9631. Some are
the result of revisions required to other NCD-related CRs released separately.
Edits to ICD-10 and other coding updates specific to NCDs will be included in
subsequent, quarterly releases as needed. No policy-related changes are
included with these updates. Any policy-related changes to NCDs continue to be
implemented via the current, long-standing NCD process. (TN 1708)
(CR9751)
11/2016 - This change
request (CR) is the 9th maintenance update of ICD-10 conversions and other
coding updates specific to national coverage determinations (NCDs). The
majority of the NCDs included are a result of feedback received from previous
ICD-10 NCD CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, and CR9631.
Some are the result of revisions required to other NCD-related CRs released
separately.
Edits to ICD-10 and other coding updates specific to NCDs will be included in
subsequent, quarterly releases as needed. No policy-related changes are
included with these updates. Any policy-related changes to NCDs continue to be
implemented via the current, long-standing NCD process. (TN 1753)
(CR9751)
02/2017 - This change
request (CR) is the 10th maintenance update of ICD-10 conversions and other
coding updates specific to national coverage determinations (NCDs). These NCD
coding changes are the result of newly available codes, coding revisions to
NCDs released separately, or coding feedback received. Previous NCD coding
changes appear in ICD-10 quarterly updates as follows: CR7818, CR8109, CR8197,
CR8691, CR9087, CR9252, CR9540, CR9631, and CR9751, as well as in CRs
implementing new policy NCDs. Edits to ICD-10 and other coding updates specific
to NCDs will be included in subsequent, quarterly releases and individual CRs
as appropriate. No policy-related changes are included with the ICD-10
quarterly updates. Any policy-related changes to NCDs continue to be
implemented via the current, long-standing NCD process. (TN 1792)
(CR9861)
05/2017 - This change
request (CR) constitutes a maintenance update of ICD-10 conversions and other
coding updates specific to national coverage determinations (NCDs). These NCD
coding changes are the result of newly available codes, coding revisions to
NCDs released separately, or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be
found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent, quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. Any policy-related changes to NCDs
continue to be implemented via the current, long-standing NCD process. (TN 1854)
(CR10086)
07/2017 - This Change
Request (CR) constitutes a maintenance update of International Code of
Diseases, Tenth Revision (ICD-10) conversions and other coding updates specific
to National Coverage Determinations (NCDs). These NCD coding changes are the
result of newly available codes, coding revisions to NCDs released separately,
or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be
found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. Any policy-related changes to NCDs
continue to be implemented via the current, long-standing NCD process. (TN 1875)
(CR10184)
11/2017 - This Change
Request (CR) constitutes a maintenance update of International Code of
Diseases, Tenth Revision (ICD-10) conversions and other coding updates specific
to National Coverage Determinations (NCDs). These NCD coding changes are the
result of newly available codes, coding revisions to NCDs released separately,
or coding feedback received. (TN 1975)
(CR10318)
01/2018 - This Change Request (CR) constitutes a maintenance update
of International Code of Diseases, Tenth Revision (ICD-10) conversions and
other coding updates specific to National Coverage Determinations (NCDs). These
NCD coding changes are the result of newly available codes, coding revisions to
NCDs released separately, or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be
found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. Any policy-related changes to NCDs
continue to be implemented via the current, long-standing NCD process. (TN
2005 ) (CR10318)
02/2018
- This Change Request (CR) constitutes a maintenance update of International
Code of Diseases, Tenth Revision (ICD-10) conversions and other coding updates
specific to National Coverage Determinations (NCDs). These NCD coding changes
are the result of newly available codes, coding revisions to NCDs released
separately, or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be
found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. Any policy-related changes to NCDs
continue to be implemented via the current, long-standing NCD process. (TN
2033 ) (CR10473)
02/2018
- Transmittal 2033, dated February 16, 2018, is being rescinded and replaced by
Transmittal 2039, dated, February 28, 2018 to correct instructions in business
requirement 7, NCD210.3, Colorectal Cancer Screening, and its accompanying
spreadsheet. All other information remains the same. (TN
2039 ) (CR10473)
05/2018
- This Change Request (CR) constitutes a maintenance update of ICD-10
conversions and other coding updates specific to NCDs. These NCD coding changes
are the result of newly available codes, coding revisions to NCDs released
separately, or coding feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be
found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. (TN
2076 ) (CR10622)
08/2018
- This Change Request (CR) constitutes a maintenance update of ICD-10
conversions and other coding updates specific to NCDs. These NCD coding changes
are the result of newly available codes, coding revisions to NCDs released
separately, or coding to feedback received.
Previous NCD coding changes appear in ICD-10 quarterly updates that can be
found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. Any policy-related changes to NCDs
continue to be implemented via the current, long-standing NCD process. (TN
2122 ) (CR10859)
09/2018 - This Change
Request (CR) constitutes a maintenance update of ICD-10 conversions and other
coding updates specific to NCDs. These NCD coding changes are the result of
newly available codes, coding revisions to NCDs released separately, or coding
feedback received.
Previous NCD coding changes appear in ICD-10
quarterly updates that can be found at https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html,
along with other CRs implementing new policy NCDs. Edits to ICD-10 and other
coding updates specific to NCDs will be included in subsequent quarterly
releases and individual CRs as appropriate. No policy-related changes are
included with the ICD-10 quarterly updates. Any policy-related changes to NCDs
continue to be implemented via the current, long-standing NCD process.(TN 2138)
(CR10859)
11/2018 - This Change
Request (CR) constitutes a maintenance update of ICD-10 conversions and other
coding updates specific to NCDs. These NCD coding changes are the result of
newly available codes, coding revisions to NCDs released separately, or coding
feedback received.
Previous NCD coding changes appear in ICD-10
quarterly updates that can be found at:
https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html, along with
other CRs implementing new policy NCDs. Edits to ICD-10 and other coding
updates specific to NCDs will be included in subsequent quarterly releases and
individual CRs as appropriate. No policy-related changes are included with the
ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be
implemented via the current, long-standing NCD process.(TN 2200) (CR10859
07/2020 - This Change
Request (CR) constitutes a maintenance update of ICD-10 conversions and other
coding updates specific to NCDs. These NCD coding changes are the result of
newly available codes, coding revisions to NCDs released separately, or coding
feedback received. (TN 10261) (CR11905)
10/2020 - This Change
Request (CR) constitutes a maintenance update of ICD-10 conversions and other
coding updates specific to NCDs. These NCD coding changes are the result of
newly available codes, coding revisions to NCDs released separately, or coding
feedback received.
Previous NCD coding changes appear in ICD-10
quarterly updates that can be found at:
https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html, along with
other CRs implementing new policy NCDs. Edits to ICD-10 and other coding
updates specific to NCDs will be included in subsequent quarterly releases and
individual CRs as appropriate. No policy-related changes are included with the
ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be
implemented via the current, longstanding NCD process. (TN 10432) (CR12027)
CR12027: Added "and R
codes" to the NOTE in the dx list that was cut off in CR10859
transmission. (The note was complete in both business requirements and
history.) Ensure edits are processing correctly. Add ICD-10 dx effective
4/1/2021 C79.51, C94.40, C94.41, C94.42, D47.Z2, D47.Z9, G13.0.
FISS to remove
RC 59240, 59241 not removed in CR 10184.
National Coverage
Analyses (NCAs)
National Coverage
Analyses (NCAs)
This NCD has been or is
currently being reviewed under the National Coverage Determination process. The
following are existing associations with NCAs, from the National Coverage
Analyses database.
·
Original
consideration for Positron Emission Tomography (FDG) (CAG-00065N)
·
Original
consideration for Positron Emission Tomography (FDG) for Breast Cancer
(CAG-00094N)
·
Second
reconsideration for Positron Emission Tomography (FDG) for Cervical Cancer
(CAG-00181R2)
·
Original
consideration for Positron Emission Tomography (FDG) for Myocardial Viability
(CAG-00098N)
·
First
reconsideration for Positron Emission Tomography (FDG) for Solid Tumors
(CAG-00181R)
·
Original
consideration for Positron Emission Tomography (FDG) for Thyroid Cancer
(CAG-00095N)
Other Versions
·
Positron
Emission Tomography (FDG) for Oncologic Conditions - Version 3, Effective
between 8/4/2010 - 6/11/2013
·
Positron
Emission Tomography (FDG) for Oncologic Conditions - Version 2,
Effective between 11/10/2009 - 8/4/2010
·
Positron
Emission Tomography (FDG) for Oncologic Conditions - Version 1,
Effective between 4/3/2009 - 11/10/2009
|
CPT/HCPCS
Codes |
|
|
78608 |
Brain imaging (pet) |
|
78811 |
Pet image ltd area |
|
78812 |
Pet image skull-thigh |
|
78813 |
Pet image full body |
|
78814 |
Pet image w/ct
lmtd |
|
78815 |
Pet image w/ct
skull-thigh |
|
78816 |
Pet image w/ct
full body |
|
A9515 |
Choline c-11 |
|
A9552 |
F18 fdg |
|
A9580 |
Sodium fluoride f-18 |
|
A9587 |
Gallium ga-68 |
|
A9588 |
Fluciclovine f-18 |
The following procedure
codes are non-covered by Medicare:
|
CPT/HCPCS
Codes |
|
|
78609 |
Brain imaging (pet) |
|
G0219 |
Pet img wholbod melano nonco |
|
G0235 |
Pet not otherwise specified |
|
G0252 |
Pet imaging initial dx |
|
ICD-10
CM |
ICD-10
DX Description |
|
|
CMS reserves the right to add or
remove codes associated with its NCDs in order to implement those NCDs in the
most efficient manner within the confines of the policy. |
|
C00.0 |
Malignant neoplasm of external
upper lip |
|
C00.1 |
Malignant neoplasm of external
lower lip |
|
C00.3 |
Malignant neoplasm of upper lip,
inner aspect |
|
C00.4 |
Malignant neoplasm of lower lip,
inner aspect |
|
C00.6 |
Malignant neoplasm of commissure
of lip, unspecified |
|
C00.8 |
Malignant neoplasm of overlapping
sites of lip |
|
C01 |
Malignant neoplasm of base of
tongue |
|
C02.0 |
Malignant neoplasm of dorsal
surface of tongue |
|
C02.1 |
Malignant neoplasm of border of
tongue |
|
C02.2 |
Malignant neoplasm of ventral
surface of tongue |
|
C02.4 |
Malignant neoplasm of lingual
tonsil |
|
C02.8 |
Malignant neoplasm of overlapping
sites of tongue |
|
C03.0 |
Malignant neoplasm of upper gum |
|
C03.1 |
Malignant neoplasm of lower gum |
|
C04.0 |
Malignant neoplasm of anterior floor
of mouth |
|
C04.1 |
Malignant neoplasm of lateral
floor of mouth |
|
C04.8 |
Malignant neoplasm of overlapping
sites of floor of mouth |
|
C05.0 |
Malignant neoplasm of hard palate |
|
C05.1 |
Malignant neoplasm of soft palate |
|
C05.2 |
Malignant neoplasm of uvula |
|
C05.8 |
Malignant neoplasm of overlapping
sites of palate |
|
C06.0 |
Malignant neoplasm of cheek mucosa |
|
C06.1 |
Malignant neoplasm of vestibule of
mouth |
|
C06.2 |
Malignant neoplasm of retromolar
area |
|
C06.89 |
Malignant neoplasm of overlapping
sites of other parts of mouth |
|
C07 |
Malignant neoplasm of parotid
gland |
|
C08.0 |
Malignant neoplasm of
submandibular gland |
|
C08.1 |
Malignant neoplasm of sublingual
gland |
|
C09.0 |
Malignant neoplasm of tonsillar
fossa |
|
C09.1 |
Malignant neoplasm of tonsillar
pillar (anterior) (posterior) |
|
C09.8 |
Malignant neoplasm of overlapping
sites of tonsil |
|
C09.9 |
Malignant neoplasm of tonsil,
unspecified |
|
C10.0 |
Malignant neoplasm of vallecula |
|
C10.1 |
Malignant neoplasm of anterior
surface of epiglottis |
|
C10.2 |
Malignant neoplasm of lateral wall
of oropharynx |
|
C10.3 |
Malignant neoplasm of posterior
wall of oropharynx |
|
C10.4 |
Malignant neoplasm of branchial
cleft |
|
C10.8 |
Malignant neoplasm of overlapping
sites of oropharynx |
|
C11.0 |
Malignant neoplasm of superior
wall of nasopharynx |
|
C11.1 |
Malignant neoplasm of posterior
wall of nasopharynx |
|
C11.2 |
Malignant neoplasm of lateral wall
of nasopharynx |
|
C11.3 |
Malignant neoplasm of anterior
wall of nasopharynx |
|
C11.8 |
Malignant neoplasm of overlapping
sites of nasopharynx |
|
C12 |
Malignant neoplasm of pyriform
sinus |
|
C13.0 |
Malignant neoplasm of postcricoid region |
|
C13.1 |
Malignant neoplasm of
aryepiglottic fold, hypopharyngeal aspect |
|
C13.2 |
Malignant neoplasm of posterior
wall of hypopharynx |
|
C13.8 |
Malignant neoplasm of overlapping
sites of hypopharynx |
|
C14.2 |
Malignant neoplasm of Waldeyer's ring |
|
C14.8 |
Malignant neoplasm of overlapping
sites of lip, oral cavity and pharynx |
|
C15.3 |
Malignant neoplasm of upper third
of esophagus |
|
C15.4 |
Malignant neoplasm of middle third
of esophagus |
|
C15.5 |
Malignant neoplasm of lower third
of esophagus |
|
C15.8 |
Malignant neoplasm of overlapping
sites of esophagus |
|
C16.0 |
Malignant neoplasm of cardia |
|
C16.1 |
Malignant neoplasm of fundus of
stomach |
|
C16.2 |
Malignant neoplasm of body of
stomach |
|
C16.3 |
Malignant neoplasm of pyloric
antrum |
|
C16.4 |
Malignant neoplasm of pylorus |
|
C16.5 |
Malignant neoplasm of lesser
curvature of stomach, unspecified |
|
C16.6 |
Malignant neoplasm of greater
curvature of stomach, unspecified |
|
C16.8 |
Malignant neoplasm of overlapping
sites of stomach |
|
C17.0 |
Malignant neoplasm of duodenum |
|
C17.1 |
Malignant neoplasm of jejunum |
|
C17.2 |
Malignant neoplasm of ileum |
|
C17.3 |
Meckel's diverticulum, malignant |
|
C17.8 |
Malignant neoplasm of overlapping
sites of small intestine |
|
C18.0 |
Malignant neoplasm of cecum |
|
C18.1 |
Malignant neoplasm of appendix |
|
C18.2 |
Malignant neoplasm of ascending
colon |
|
C18.3 |
Malignant neoplasm of hepatic
flexure |
|
C18.4 |
Malignant neoplasm of transverse
colon |
|
C18.5 |
Malignant neoplasm of splenic
flexure |
|
C18.6 |
Malignant neoplasm of descending
colon |
|
C18.7 |
Malignant neoplasm of sigmoid
colon |
|
C18.8 |
Malignant neoplasm of overlapping
sites of colon |
|
C19 |
Malignant neoplasm of rectosigmoid
junction |
|
C20 |
Malignant neoplasm of rectum |
|
C21.1 |
Malignant neoplasm of anal canal |
|
C21.2 |
Malignant neoplasm of cloacogenic zone |
|
C21.8 |
Malignant neoplasm of overlapping
sites of rectum, anus and anal canal |
|
C22.0 |
Liver cell carcinoma |
|
C22.1 |
Intrahepatic bile duct carcinoma |
|
C22.2 |
Hepatoblastoma |
|
C22.3 |
Angiosarcoma of liver |
|
C22.4 |
Other sarcomas of liver |
|
C22.7 |
Other specified carcinomas of
liver |
|
C22.8 |
Malignant neoplasm of liver,
primary, unspecified as to type |
|
C22.9 |
Malignant neoplasm of liver, not
specified as primary or secondary |
|
C23 |
Malignant neoplasm of gallbladder |
|
C24.0 |
Malignant neoplasm of extrahepatic
bile duct |
|
C24.1 |
Malignant neoplasm of ampulla of Vater |
|
C24.8 |
Malignant neoplasm of overlapping
sites of biliary tract |
|
C25.0 |
Malignant neoplasm of head of
pancreas |
|
C25.1 |
Malignant neoplasm of body of
pancreas |
|
C25.2 |
Malignant neoplasm of tail of
pancreas |
|
C25.3 |
Malignant neoplasm of pancreatic
duct |
|
C25.4 |
Malignant neoplasm of endocrine
pancreas |
|
C25.7 |
Malignant neoplasm of other parts
of pancreas |
|
C25.8 |
Malignant neoplasm of overlapping
sites of pancreas |
|
C26.1 |
Malignant neoplasm of spleen |
|
C30.0 |
Malignant neoplasm of nasal cavity |
|
C30.1 |
Malignant neoplasm of middle ear |
|
C31.0 |
Malignant neoplasm of maxillary
sinus |
|
C31.1 |
Malignant neoplasm of ethmoidal
sinus |
|
C31.2 |
Malignant neoplasm of frontal
sinus |
|
C31.3 |
Malignant neoplasm of sphenoid
sinus |
|
C31.8 |
Malignant neoplasm of overlapping
sites of accessory sinuses |
|
C32.0 |
Malignant neoplasm of glottis |
|
C32.1 |
Malignant neoplasm of supraglottis |
|
C32.2 |
Malignant neoplasm of subglottis |
|
C32.3 |
Malignant neoplasm of laryngeal
cartilage |
|
C32.8 |
Malignant neoplasm of overlapping
sites of larynx |
|
C33 |
Malignant neoplasm of trachea |
|
C34.01 |
Malignant neoplasm of right main
bronchus |
|
C34.02 |
Malignant neoplasm of left main
bronchus |
|
C34.11 |
Malignant neoplasm of upper lobe,
right bronchus or lung |
|
C34.12 |
Malignant neoplasm of upper lobe,
left bronchus or lung |
|
C34.2 |
Malignant neoplasm of middle lobe,
bronchus or lung |
|
C34.31 |
Malignant neoplasm of lower lobe,
right bronchus or lung |
|
C34.32 |
Malignant neoplasm of lower lobe,
left bronchus or lung |
|
C34.81 |
Malignant neoplasm of overlapping
sites of right bronchus and lung |
|
C34.82 |
Malignant neoplasm of overlapping
sites of left bronchus and lung |
|
C37 |
Malignant neoplasm of thymus |
|
C38.0 |
Malignant neoplasm of heart |
|
C38.1 |
Malignant neoplasm of anterior
mediastinum |
|
C38.2 |
Malignant neoplasm of posterior
mediastinum |
|
C38.4 |
Malignant neoplasm of pleura |
|
C38.8 |
Malignant neoplasm of overlapping
sites of heart, mediastinum and pleura |
|
C40.01 |
Malignant neoplasm of scapula and
long bones of right upper limb |
|
C40.02 |
Malignant neoplasm of scapula and
long bones of left upper limb |
|
C40.11 |
Malignant neoplasm of short bones
of right upper limb |
|
C40.12 |
Malignant neoplasm of short bones
of left upper limb |
|
C40.21 |
Malignant neoplasm of long bones
of right lower limb |
|
C40.22 |
Malignant neoplasm of long bones
of left lower limb |
|
C40.31 |
Malignant neoplasm of short bones
of right lower limb |
|
C40.32 |
Malignant neoplasm of short bones
of left lower limb |
|
C40.81 |
Malignant neoplasm of overlapping
sites of bone and articular cartilage of right limb |
|
C40.82 |
Malignant neoplasm of overlapping
sites of bone and articular cartilage of left limb |
|
C40.91 |
Malignant neoplasm of unspecified
bones and articular cartilage of right limb |
|
C40.92 |
Malignant neoplasm of unspecified
bones and articular cartilage of left limb |
|
C41.0 |
Malignant neoplasm of bones of
skull and face |
|
C41.1 |
Malignant neoplasm of mandible |
|
C41.2 |
Malignant neoplasm of vertebral
column |
|
C41.3 |
Malignant neoplasm of ribs,
sternum and clavicle |
|
C41.4 |
Malignant neoplasm of pelvic
bones, sacrum and coccyx |
|
C41.9 |
Malignant neoplasm of bone and
articular cartilage, unspecified |
|
C43.0 |
Malignant melanoma of lip |
|
C43.111 |
Malignant melanoma of right upper
eyelid, including canthus |
|
C43.112 |
Malignant melanoma of right lower
eyelid, including canthus |
|
C43.121 |
Malignant melanoma of left upper
eyelid, including canthus |
|
C43.122 |
Malignant melanoma of left lower
eyelid, including canthus |
|
C43.21 |
Malignant melanoma of right ear
and external auricular canal |
|
C43.22 |
Malignant melanoma of left ear and
external auricular canal |
|
C43.31 |
Malignant melanoma of nose |
|
C43.39 |
Malignant melanoma of other parts
of face |
|
C43.4 |
Malignant melanoma of scalp and
neck |
|
C43.51 |
Malignant melanoma of anal skin |
|
C43.52 |
Malignant melanoma of skin of
breast |
|
C43.59 |
Malignant melanoma of other part
of trunk |
|
C43.61 |
Malignant melanoma of right upper
limb, including shoulder |
|
C43.62 |
Malignant melanoma of left upper
limb, including shoulder |
|
C43.71 |
Malignant melanoma of right lower
limb, including hip |
|
C43.72 |
Malignant melanoma of left lower
limb, including hip |
|
C43.8 |
Malignant melanoma of overlapping
sites of skin |
|
C44.00 |
Unspecified malignant neoplasm of
skin of lip |
|
C44.01 |
Basal cell carcinoma of skin of
lip |
|
C44.02 |
Squamous cell carcinoma of skin of
lip |
|
C44.09 |
Other specified malignant neoplasm
of skin of lip |
|
C44.1021 |
Unspecified malignant neoplasm of
skin of right upper eyelid, including canthus |
|
C44.1022 |
Unspecified malignant neoplasm of
skin of right lower eyelid, including canthus |
|
C44.1091 |
Unspecified malignant neoplasm of
skin of left upper eyelid, including canthus |
|
C44.1092 |
Unspecified malignant neoplasm of
skin of left lower eyelid, including canthus |
|
C44.1121 |
Basal cell carcinoma of skin of
right upper eyelid, including canthus |
|
C44.1122 |
Basal cell carcinoma of skin of
right lower eyelid, including canthus |
|
C44.1191 |
Basal cell carcinoma of skin of
left upper eyelid, including canthus |
|
C44.1192 |
Basal cell carcinoma of skin of
left lower eyelid, including canthus |
|
C44.1221 |
Squamous cell carcinoma of skin of
right upper eyelid, including canthus |
|
C44.1222 |
Squamous cell carcinoma of skin of
right lower eyelid, including canthus |
|
C44.1291 |
Squamous cell carcinoma of skin of
left upper eyelid, including canthus |
|
C44.1292 |
Squamous cell carcinoma of skin of
left lower eyelid, including canthus |
|
C44.1921 |
Other specified malignant neoplasm
of skin of right upper eyelid, including canthus |
|
C44.1922 |
Other specified malignant neoplasm
of skin of right lower eyelid, including canthus |
|
C44.1991 |
Other specified malignant neoplasm
of skin of left upper eyelid, including canthus |
|
C44.1992 |
Other specified malignant neoplasm
of skin of left lower eyelid, including canthus |
|
C44.202 |
Unspecified malignant neoplasm of
skin of right ear and external auricular canal |
|
C44.209 |
Unspecified malignant neoplasm of
skin of left ear and external auricular canal |
|
C44.212 |
Basal cell carcinoma of skin of
right ear and external auricular canal |
|
C44.219 |
Basal cell carcinoma of skin of
left ear and external auricular canal |
|
C44.222 |
Squamous cell carcinoma of skin of
right ear and external auricular canal |
|
C44.229 |
Squamous cell carcinoma of skin of
left ear and external auricular canal |
|
C44.292 |
Other specified malignant neoplasm
of skin of right ear and external auricular canal |
|
C44.299 |
Other specified malignant neoplasm
of skin of left ear and external auricular canal |
|
C44.301 |
Unspecified malignant neoplasm of
skin of nose |
|
C44.309 |
Unspecified malignant neoplasm of
skin of other parts of face |
|
C44.311 |
Basal cell carcinoma of skin of
nose |
|
C44.319 |
Basal cell carcinoma of skin of
other parts of face |
|
C44.321 |
Squamous cell carcinoma of skin of
nose |
|
C44.329 |
Squamous cell carcinoma of skin of
other parts of face |
|
C44.391 |
Other specified malignant neoplasm
of skin of nose |
|
C44.399 |
Other specified malignant neoplasm
of skin of other parts of face |
|
C44.40 |
Unspecified malignant neoplasm of
skin of scalp and neck |
|
C44.41 |
Basal cell carcinoma of skin of
scalp and neck |
|
C44.42 |
Squamous cell carcinoma of skin of
scalp and neck |
|
C44.49 |
Other specified malignant neoplasm
of skin of scalp and neck |
|
C44.500 |
Unspecified malignant neoplasm of
anal skin |
|
C44.501 |
Unspecified malignant neoplasm of
skin of breast |
|
C44.509 |
Unspecified malignant neoplasm of
skin of other part of trunk |
|
C44.510 |
Basal cell carcinoma of anal skin |
|
C44.511 |
Basal cell carcinoma of skin of
breast |
|
C44.519 |
Basal cell carcinoma of skin of
other part of trunk |
|
C44.520 |
Squamous cell carcinoma of anal
skin |
|
C44.521 |
Squamous cell carcinoma of skin of
breast |
|
C44.529 |
Squamous cell carcinoma of skin of
other part of trunk |
|
C44.590 |
Other specified malignant neoplasm
of anal skin |
|
C44.591 |
Other specified malignant neoplasm
of skin of breast |
|
C44.599 |
Other specified malignant neoplasm
of skin of other part of trunk |
|
C44.602 |
Unspecified malignant neoplasm of
skin of right upper limb, including shoulder |
|
C44.609 |
Unspecified malignant neoplasm of
skin of left upper limb, including shoulder |
|
C44.612 |
Basal cell carcinoma of skin of
right upper limb, including shoulder |
|
C44.619 |
Basal cell carcinoma of skin of
left upper limb, including shoulder |
|
C44.622 |
Squamous cell carcinoma of skin of
right upper limb, including shoulder |
|
C44.629 |
Squamous cell carcinoma of skin of
left upper limb, including shoulder |
|
C44.692 |
Other specified malignant neoplasm
of skin of right upper limb, including shoulder |
|
C44.699 |
Other specified malignant neoplasm
of skin of left upper limb, including shoulder |
|
C44.702 |
Unspecified malignant neoplasm of
skin of right lower limb, including hip |
|
C44.709 |
Unspecified malignant neoplasm of
skin of left lower limb, including hip |
|
C44.712 |
Basal cell carcinoma of skin of
right lower limb, including hip |
|
C44.719 |
Basal cell carcinoma of skin of
left lower limb, including hip |
|
C44.722 |
Squamous cell carcinoma of skin of
right lower limb, including hip |
|
C44.729 |
Squamous cell carcinoma of skin of
left lower limb, including hip |
|
C44.792 |
Other specified malignant neoplasm
of skin of right lower limb, including hip |
|
C44.799 |
Other specified malignant neoplasm
of skin of left lower limb, including hip |
|
C44.80 |
Unspecified malignant neoplasm of
overlapping sites of skin |
|
C44.81 |
Basal cell carcinoma of
overlapping sites of skin |
|
C44.82 |
Squamous cell carcinoma of
overlapping sites of skin |
|
C44.89 |
Other specified malignant neoplasm
of overlapping sites of skin |
|
C45.0 |
Mesothelioma of pleura |
|
C45.1 |
Mesothelioma of peritoneum |
|
C45.2 |
Mesothelioma of pericardium |
|
C45.7 |
Mesothelioma of other sites |
|
C46.0 |
Kaposi's sarcoma of skin |
|
C46.1 |
Kaposi's sarcoma of soft tissue |
|
C46.2 |
Kaposi's sarcoma of palate |
|
C46.3 |
Kaposi's sarcoma of lymph nodes |
|
C46.4 |
Kaposi's sarcoma of
gastrointestinal sites |
|
C46.51 |
Kaposi's sarcoma of right lung |
|
C46.52 |
Kaposi's sarcoma of left lung |
|
C46.7 |
Kaposi's sarcoma of other sites |
|
C47.0 |
Malignant neoplasm of peripheral
nerves of head, face and neck |
|
C47.11 |
Malignant neoplasm of peripheral
nerves of right upper limb, including shoulder |
|
C47.12 |
Malignant neoplasm of peripheral
nerves of left upper limb, including shoulder |
|
C47.21 |
Malignant neoplasm of peripheral
nerves of right lower limb, including hip |
|
C47.22 |
Malignant neoplasm of peripheral
nerves of left lower limb, including hip |
|
C47.3 |
Malignant neoplasm of peripheral
nerves of thorax |
|
C47.4 |
Malignant neoplasm of peripheral
nerves of abdomen |
|
C47.5 |
Malignant neoplasm of peripheral
nerves of pelvis |
|
C47.8 |
Malignant neoplasm of overlapping
sites of peripheral nerves and autonomic nervous system |
|
C48.0 |
Malignant neoplasm of
retroperitoneum |
|
C48.1 |
Malignant neoplasm of specified
parts of peritoneum |
|
C48.8 |
Malignant neoplasm of overlapping
sites of retroperitoneum and peritoneum |
|
C49.0 |
Malignant neoplasm of connective
and soft tissue of head, face and neck |
|
C49.11 |
Malignant neoplasm of connective
and soft tissue of right upper limb, including shoulder |
|
C49.12 |
Malignant neoplasm of connective
and soft tissue of left upper limb, including shoulder |
|
C49.21 |
Malignant neoplasm of connective
and soft tissue of right lower limb, including hip |
|
C49.22 |
Malignant neoplasm of connective
and soft tissue of left lower limb, including hip |
|
C49.3 |
Malignant neoplasm of connective
and soft tissue of thorax |
|
C49.4 |
Malignant neoplasm of connective
and soft tissue of abdomen |
|
C49.5 |
Malignant neoplasm of connective
and soft tissue of pelvis |
|
C49.8 |
Malignant neoplasm of overlapping
sites of connective and soft tissue |
|
C49.A1 |
Gastrointestinal stromal tumor of
esophagus |
|
C49.A2 |
Gastrointestinal stromal tumor of
stomach |
|
C49.A3 |
Gastrointestinal stromal tumor of
small intestine |
|
C49.A4 |
Gastrointestinal stromal tumor of
large intestine |
|
C49.A5 |
Gastrointestinal stromal tumor of
rectum |
|
C49.A9 |
Gastrointestinal stromal tumor of
other sites |
|
C4A.0 |
Merkel cell carcinoma of lip |
|
C4A.111 |
Merkel cell carcinoma of right
upper eyelid, including canthus |
|
C4A.112 |
Merkel cell carcinoma of right
lower eyelid, including canthus |
|
C4A.121 |
Merkel cell carcinoma of left
upper eyelid, including canthus |
|
C4A.122 |
Merkel cell carcinoma of left
lower eyelid, including canthus |
|
C4A.21 |
Merkel cell carcinoma of right ear
and external auricular canal |
|
C4A.22 |
Merkel cell carcinoma of left ear
and external auricular canal |
|
C4A.31 |
Merkel cell carcinoma of nose |
|
C4A.39 |
Merkel cell carcinoma of other
parts of face |
|
C4A.4 |
Merkel cell carcinoma of scalp and
neck |
|
C4A.51 |
Merkel cell carcinoma of anal skin |
|
C4A.52 |
Merkel cell carcinoma of skin of
breast |
|
C4A.59 |
Merkel cell carcinoma of other
part of trunk |
|
C4A.61 |
Merkel cell carcinoma of right
upper limb, including shoulder |
|
C4A.62 |
Merkel cell carcinoma of left
upper limb, including shoulder |
|
C4A.71 |
Merkel cell carcinoma of right
lower limb, including hip |
|
C4A.72 |
Merkel cell carcinoma of left
lower limb, including hip |
|
C4A.8 |
Merkel cell carcinoma of
overlapping sites |
|
C50.011 |
Malignant neoplasm of nipple and
areola, right female breast |
|
C50.012 |
Malignant neoplasm of nipple and
areola, left female breast |
|
C50.021 |
Malignant neoplasm of nipple and
areola, right male breast |
|
C50.022 |
Malignant neoplasm of nipple and
areola, left male breast |
|
C50.111 |
Malignant neoplasm of central
portion of right female breast |
|
C50.112 |
Malignant neoplasm of central
portion of left female breast |
|
C50.121 |
Malignant neoplasm of central
portion of right male breast |
|
C50.122 |
Malignant neoplasm of central
portion of left male breast |
|
C50.211 |
Malignant neoplasm of upper-inner quadrant
of right female breast |
|
C50.212 |
Malignant neoplasm of upper-inner
quadrant of left female breast |
|
C50.221 |
Malignant neoplasm of upper-inner
quadrant of right male breast |
|
C50.222 |
Malignant neoplasm of upper-inner
quadrant of left male breast |
|
C50.311 |
Malignant neoplasm of lower-inner
quadrant of right female breast |
|
C50.312 |
Malignant neoplasm of lower-inner
quadrant of left female breast |
|
C50.321 |
Malignant neoplasm of lower-inner
quadrant of right male breast |
|
C50.322 |
Malignant neoplasm of lower-inner
quadrant of left male breast |
|
C50.411 |
Malignant neoplasm of upper-outer
quadrant of right female breast |
|
C50.412 |
Malignant neoplasm of upper-outer
quadrant of left female breast |
|
C50.421 |
Malignant neoplasm of upper-outer
quadrant of right male breast |
|
C50.422 |
Malignant neoplasm of upper-outer
quadrant of left male breast |
|
C50.511 |
Malignant neoplasm of lower-outer
quadrant of right female breast |
|
C50.512 |
Malignant neoplasm of lower-outer
quadrant of left female breast |
|
C50.521 |
Malignant neoplasm of lower-outer
quadrant of right male breast |
|
C50.522 |
Malignant neoplasm of lower-outer
quadrant of left male breast |
|
C50.611 |
Malignant neoplasm of axillary
tail of right female breast |
|
C50.612 |
Malignant neoplasm of axillary
tail of left female breast |
|
C50.621 |
Malignant neoplasm of axillary
tail of right male breast |
|
C50.622 |
Malignant neoplasm of axillary
tail of left male breast |
|
C50.811 |
Malignant neoplasm of overlapping
sites of right female breast |
|
C50.812 |
Malignant neoplasm of overlapping
sites of left female breast |
|
C50.821 |
Malignant neoplasm of overlapping
sites of right male breast |
|
C50.822 |
Malignant neoplasm of overlapping
sites of left male breast |
|
C51.0 |
Malignant neoplasm of labium majus |
|
C51.1 |
Malignant neoplasm of labium minus |
|
C51.2 |
Malignant neoplasm of clitoris |
|
C51.8 |
Malignant neoplasm of overlapping
sites of vulva |
|
C52 |
Malignant neoplasm of vagina |
|
C53.0 |
Malignant neoplasm of endocervix |
|
C53.1 |
Malignant neoplasm of exocervix |
|
C53.8 |
Malignant neoplasm of overlapping
sites of cervix uteri |
|
C54.0 |
Malignant neoplasm of isthmus
uteri |
|
C54.1 |
Malignant neoplasm of endometrium |
|
C54.2 |
Malignant neoplasm of myometrium |
|
C54.3 |
Malignant neoplasm of fundus uteri |
|
C54.8 |
Malignant neoplasm of overlapping
sites of corpus uteri |
|
C56.1 |
Malignant neoplasm of right ovary |
|
C56.2 |
Malignant neoplasm of left ovary |
|
C57.01 |
Malignant neoplasm of right
fallopian tube |
|
C57.02 |
Malignant neoplasm of left
fallopian tube |
|
C57.11 |
Malignant neoplasm of right broad
ligament |
|
C57.12 |
Malignant neoplasm of left broad
ligament |
|
C57.21 |
Malignant neoplasm of right round
ligament |
|
C57.22 |
Malignant neoplasm of left round
ligament |
|
C57.3 |
Malignant neoplasm of parametrium |
|
C57.4 |
Malignant neoplasm of uterine
adnexa, unspecified |
|
C57.7 |
Malignant neoplasm of other
specified female genital organs |
|
C57.8 |
Malignant neoplasm of overlapping
sites of female genital organs |
|
C58 |
Malignant neoplasm of placenta |
|
C60.0 |
Malignant neoplasm of prepuce |
|
C60.1 |
Malignant neoplasm of glans penis |
|
C60.2 |
Malignant neoplasm of body of
penis |
|
C60.8 |
Malignant neoplasm of overlapping
sites of penis |
|
C61 |
Malignant neoplasm of prostate |
|
C62.01 |
Malignant neoplasm of undescended
right testis |
|
C62.02 |
Malignant neoplasm of undescended
left testis |
|
C62.11 |
Malignant neoplasm of descended
right testis |
|
C62.12 |
Malignant neoplasm of descended
left testis |
|
C63.01 |
Malignant neoplasm of right
epididymis |
|
C63.02 |
Malignant neoplasm of left
epididymis |
|
C63.11 |
Malignant neoplasm of right
spermatic cord |
|
C63.12 |
Malignant neoplasm of left
spermatic cord |
|
C63.2 |
Malignant neoplasm of scrotum |
|
C63.7 |
Malignant neoplasm of other
specified male genital organs |
|
C63.8 |
Malignant neoplasm of overlapping
sites of male genital organs |
|
C64.1 |
Malignant neoplasm of right
kidney, except renal pelvis |
|
C64.2 |
Malignant neoplasm of left kidney,
except renal pelvis |
|
C65.1 |
Malignant neoplasm of right renal
pelvis |
|
C65.2 |
Malignant neoplasm of left renal
pelvis |
|
C66.1 |
Malignant neoplasm of right ureter |
|
C66.2 |
Malignant neoplasm of left ureter |
|
C67.0 |
Malignant neoplasm of trigone of
bladder |
|
C67.1 |
Malignant neoplasm of dome of
bladder |
|
C67.2 |
Malignant neoplasm of lateral wall
of bladder |
|
C67.3 |
Malignant neoplasm of anterior
wall of bladder |
|
C67.4 |
Malignant neoplasm of posterior
wall of bladder |
|
C67.5 |
Malignant neoplasm of bladder neck |
|
C67.6 |
Malignant neoplasm of ureteric
orifice |
|
C67.7 |
Malignant neoplasm of urachus |
|
C67.8 |
Malignant neoplasm of overlapping
sites of bladder |
|
C68.0 |
Malignant neoplasm of urethra |
|
C68.1 |
Malignant neoplasm of paraurethral
glands |
|
C68.8 |
Malignant neoplasm of overlapping
sites of urinary organs |
|
C69.01 |
Malignant neoplasm of right
conjunctiva |
|
C69.02 |
Malignant neoplasm of left
conjunctiva |
|
C69.11 |
Malignant neoplasm of right cornea |
|
C69.12 |
Malignant neoplasm of left cornea |
|
C69.21 |
Malignant neoplasm of right retina |
|
C69.22 |
Malignant neoplasm of left retina |
|
C69.31 |
Malignant neoplasm of right
choroid |
|
C69.32 |
Malignant neoplasm of left choroid |
|
C69.41 |
Malignant neoplasm of right
ciliary body |
|
C69.42 |
Malignant neoplasm of left ciliary
body |
|
C69.51 |
Malignant neoplasm of right
lacrimal gland and duct |
|
C69.52 |
Malignant neoplasm of left
lacrimal gland and duct |
|
C69.61 |
Malignant neoplasm of right orbit |
|
C69.62 |
Malignant neoplasm of left orbit |
|
C69.81 |
Malignant neoplasm of overlapping
sites of right eye and adnexa |
|
C69.82 |
Malignant neoplasm of overlapping
sites of left eye and adnexa |
|
C70.0 |
Malignant neoplasm of cerebral
meninges |
|
C70.1 |
Malignant neoplasm of spinal
meninges |
|
C71.0 |
Malignant neoplasm of cerebrum,
except lobes and ventricles |
|
C71.1 |
Malignant neoplasm of frontal lobe |
|
C71.2 |
Malignant neoplasm of temporal
lobe |
|
C71.3 |
Malignant neoplasm of parietal
lobe |
|
C71.4 |
Malignant neoplasm of occipital
lobe |
|
C71.5 |
Malignant neoplasm of cerebral
ventricle |
|
C71.6 |
Malignant neoplasm of cerebellum |
|
C71.7 |
Malignant neoplasm of brain stem |
|
C71.8 |
Malignant neoplasm of overlapping
sites of brain |
|
C72.0 |
Malignant neoplasm of spinal cord |
|
C72.1 |
Malignant neoplasm of cauda equina |
|
C72.21 |
Malignant neoplasm of right
olfactory nerve |
|
C72.22 |
Malignant neoplasm of left
olfactory nerve |
|
C72.31 |
Malignant neoplasm of right optic
nerve |
|
C72.32 |
Malignant neoplasm of left optic
nerve |
|
C72.41 |
Malignant neoplasm of right
acoustic nerve |
|
C72.42 |
Malignant neoplasm of left
acoustic nerve |
|
C72.59 |
Malignant neoplasm of other
cranial nerves |
|
C73 |
Malignant neoplasm of thyroid
gland |
|
C74.01 |
Malignant neoplasm of cortex of
right adrenal gland |
|
C74.02 |
Malignant neoplasm of cortex of
left adrenal gland |
|
C74.11 |
Malignant neoplasm of medulla of
right adrenal gland |
|
C74.12 |
Malignant neoplasm of medulla of
left adrenal gland |
|
C74.91 |
Malignant neoplasm of unspecified
part of right adrenal gland |
|
C74.92 |
Malignant neoplasm of unspecified
part of left adrenal gland |
|
C75.0 |
Malignant neoplasm of parathyroid
gland |
|
C75.1 |
Malignant neoplasm of pituitary
gland |
|
C75.2 |
Malignant neoplasm of craniopharyngeal duct |
|
C75.3 |
Malignant neoplasm of pineal gland |
|
C75.4 |
Malignant neoplasm of carotid body |
|
C75.5 |
Malignant neoplasm of aortic body
and other paraganglia |
|
C75.8 |
Malignant neoplasm with
pluriglandular involvement, unspecified |
|
C76.0 |
Malignant neoplasm of head, face
and neck |
|
C76.1 |
Malignant neoplasm of thorax |
|
C76.2 |
Malignant neoplasm of abdomen |
|
C76.3 |
Malignant neoplasm of pelvis |
|
C76.41 |
Malignant neoplasm of right upper
limb |
|
C76.42 |
Malignant neoplasm of left upper
limb |
|
C76.51 |
Malignant neoplasm of right lower
limb |
|
C76.52 |
Malignant neoplasm of left lower
limb |
|
C76.8 |
Malignant neoplasm of other
specified ill-defined sites |
|
C77.0 |
Secondary and unspecified
malignant neoplasm of lymph nodes of head, face and neck |
|
C77.1 |
Secondary and unspecified
malignant neoplasm of intrathoracic lymph nodes |
|
C77.2 |
Secondary and unspecified
malignant neoplasm of intra-abdominal lymph nodes |
|
C77.3 |
Secondary and unspecified
malignant neoplasm of axilla and upper limb lymph nodes |
|
C77.4 |
Secondary and unspecified
malignant neoplasm of inguinal and lower limb lymph nodes |
|
C77.5 |
Secondary and unspecified
malignant neoplasm of intrapelvic lymph nodes |
|
C77.8 |
Secondary and unspecified
malignant neoplasm of lymph nodes of multiple regions |
|
C78.01 |
Secondary malignant neoplasm of
right lung |
|
C78.02 |
Secondary malignant neoplasm of
left lung |
|
C78.1 |
Secondary malignant neoplasm of
mediastinum |
|
C78.2 |
Secondary malignant neoplasm of
pleura |
|
C78.39 |
Secondary malignant neoplasm of
other respiratory organs |
|
C78.4 |
Secondary malignant neoplasm of
small intestine |
|
C78.5 |
Secondary malignant neoplasm of
large intestine and rectum |
|
C78.6 |
Secondary malignant neoplasm of
retroperitoneum and peritoneum |
|
C78.7 |
Secondary malignant neoplasm of
liver and intrahepatic bile duct |
|
C78.89 |
Secondary malignant neoplasm of
other digestive organs |
|
C79.01 |
Secondary malignant neoplasm of
right kidney and renal pelvis |
|
C79.02 |
Secondary malignant neoplasm of
left kidney and renal pelvis |
|
C79.11 |
Secondary malignant neoplasm of
bladder |
|
C79.19 |
Secondary malignant neoplasm of
other urinary organs |
|
C79.2 |
Secondary malignant neoplasm of
skin |
|
C79.31 |
Secondary malignant neoplasm of
brain |
|
C79.32 |
Secondary malignant neoplasm of
cerebral meninges |
|
C79.49 |
Secondary malignant neoplasm of
other parts of nervous system |
|
C79.51 |
Secondary malignant
neoplasm of the bone |
|
C79.61 |
Secondary malignant neoplasm of
right ovary |
|
C79.62 |
Secondary malignant neoplasm of
left ovary |
|
C79.71 |
Secondary malignant neoplasm of
right adrenal gland |
|
C79.72 |
Secondary malignant neoplasm of
left adrenal gland |
|
C79.81 |
Secondary malignant neoplasm of
breast |
|
C79.82 |
Secondary malignant neoplasm of
genital organs |
|
C79.89 |
Secondary malignant neoplasm of
other specified sites |
|
C7A.010 |
Malignant carcinoid tumor of the
duodenum |
|
C7A.011 |
Malignant carcinoid tumor of the
jejunum |
|
C7A.012 |
Malignant carcinoid tumor of the
ileum |
|
C7A.019 |
Malignant carcinoid tumor of the
small intestine, unspecified portion |
|
C7A.020 |
Malignant carcinoid tumor of the
appendix |
|
C7A.021 |
Malignant carcinoid tumor of the
cecum |
|
C7A.022 |
Malignant carcinoid tumor of the
ascending colon |
|
C7A.023 |
Malignant carcinoid tumor of the
transverse colon |
|
C7A.024 |
Malignant carcinoid tumor of the
descending colon |
|
C7A.025 |
Malignant carcinoid tumor of the
sigmoid colon |
|
C7A.026 |
Malignant carcinoid tumor of the
rectum |
|
C7A.029 |
Malignant carcinoid tumor of the
large intestine, unspecified portion |
|
C7A.090 |
Malignant carcinoid tumor of the
bronchus and lung |
|
C7A.091 |
Malignant carcinoid tumor of the
thymus |
|
C7A.092 |
Malignant carcinoid tumor of the
stomach |
|
C7A.093 |
Malignant carcinoid tumor of the
kidney |
|
C7A.098 |
Malignant carcinoid tumors of
other sites |
|
C7A.1 |
Malignant poorly differentiated
neuroendocrine tumors |
|
C7A.8 |
Other malignant neuroendocrine
tumors |
|
C7B.01 |
Secondary carcinoid tumors of
distant lymph nodes |
|
C7B.02 |
Secondary carcinoid tumors of
liver |
|
C7B.03 |
Secondary carcinoid tumors of bone |
|
C7B.04 |
Secondary carcinoid tumors of
peritoneum |
|
C7B.09 |
Secondary carcinoid tumors of
other sites |
|
C7B.1 |
Secondary Merkel cell carcinoma |
|
C7B.8 |
Other secondary neuroendocrine
tumors |
|
C80.2 |
Malignant neoplasm associated with
transplanted organ |
|
C81.01 |
Nodular lymphocyte predominant
Hodgkin lymphoma, lymph nodes of head, face, and neck |
|
C81.02 |
Nodular lymphocyte predominant
Hodgkin lymphoma, intrathoracic lymph nodes |
|
C81.03 |
Nodular lymphocyte predominant
Hodgkin lymphoma, intra-abdominal lymph nodes |
|
C81.04 |
Nodular lymphocyte predominant
Hodgkin lymphoma, lymph nodes of axilla and upper limb |
|
C81.05 |
Nodular lymphocyte predominant
Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
|
C81.06 |
Nodular lymphocyte predominant
Hodgkin lymphoma, intrapelvic lymph nodes |
|
C81.07 |
Nodular lymphocyte predominant
Hodgkin lymphoma, spleen |
|
C81.08 |
Nodular lymphocyte predominant
Hodgkin lymphoma, lymph nodes of multiple sites |
|
C81.09 |
Nodular lymphocyte predominant
Hodgkin lymphoma, extranodal and solid organ sites |
|
C81.11 |
Nodular sclerosis Hodgkin
lymphoma, lymph nodes of head, face, and neck |
|
C81.12 |
Nodular sclerosis Hodgkin
lymphoma, intrathoracic lymph nodes |
|
C81.13 |
Nodular sclerosis Hodgkin
lymphoma, intra-abdominal lymph nodes |
|
C81.14 |
Nodular sclerosis Hodgkin
lymphoma, lymph nodes of axilla and upper limb |
|
C81.15 |
Nodular sclerosis Hodgkin
lymphoma, lymph nodes of inguinal region and lower limb |
|
C81.16 |
Nodular sclerosis Hodgkin
lymphoma, intrapelvic lymph nodes |
|
C81.17 |
Nodular sclerosis Hodgkin
lymphoma, spleen |
|
C81.18 |
Nodular sclerosis Hodgkin
lymphoma, lymph nodes of multiple sites |
|
C81.19 |
Nodular sclerosis Hodgkin
lymphoma, extranodal and solid organ sites |
|
C81.21 |
Mixed cellularity Hodgkin
lymphoma, lymph nodes of head, face, and neck |
|
C81.22 |
Mixed cellularity Hodgkin
lymphoma, intrathoracic lymph nodes |
|
C81.23 |
Mixed cellularity Hodgkin
lymphoma, intra-abdominal lymph nodes |
|
C81.24 |
Mixed cellularity Hodgkin
lymphoma, lymph nodes of axilla and upper limb |
|
C81.25 |
Mixed cellularity Hodgkin
lymphoma, lymph nodes of inguinal region and lower limb |
|
C81.26 |
Mixed cellularity Hodgkin
lymphoma, intrapelvic lymph nodes |
|
C81.27 |
Mixed cellularity Hodgkin
lymphoma, spleen |
|
C81.28 |
Mixed cellularity Hodgkin
lymphoma, lymph nodes of multiple sites |
|
C81.29 |
Mixed cellularity Hodgkin
lymphoma, extranodal and solid organ sites |
|
C81.31 |
Lymphocyte depleted Hodgkin
lymphoma, lymph nodes of head, face, and neck |
|
C81.32 |
Lymphocyte depleted Hodgkin
lymphoma, intrathoracic lymph nodes |
|
C81.33 |
Lymphocyte depleted Hodgkin
lymphoma, intra-abdominal lymph nodes |
|
C81.34 |
Lymphocyte depleted Hodgkin
lymphoma, lymph nodes of axilla and upper limb |
|
C81.35 |
Lymphocyte depleted Hodgkin
lymphoma, lymph nodes of inguinal region and lower limb |
|
C81.36 |
Lymphocyte depleted Hodgkin
lymphoma, intrapelvic lymph nodes |
|
C81.37 |
Lymphocyte depleted Hodgkin
lymphoma, spleen |
|
C81.38 |
Lymphocyte depleted Hodgkin
lymphoma, lymph nodes of multiple sites |
|
C81.39 |
Lymphocyte depleted Hodgkin
lymphoma, extranodal and solid organ sites |
|
C81.41 |
Lymphocyte-rich Hodgkin lymphoma,
lymph nodes of head, face, and neck |
|
C81.42 |
Lymphocyte-rich Hodgkin lymphoma,
intrathoracic lymph nodes |
|
C81.43 |
Lymphocyte-rich Hodgkin lymphoma,
intra-abdominal lymph nodes |
|
C81.44 |
Lymphocyte-rich Hodgkin lymphoma,
lymph nodes of axilla and upper limb |
|
C81.45 |
Lymphocyte-rich Hodgkin lymphoma,
lymph nodes of inguinal region and lower limb |
|
C81.46 |
Lymphocyte-rich Hodgkin lymphoma,
intrapelvic lymph nodes |
|
C81.47 |
Lymphocyte-rich Hodgkin lymphoma,
spleen |
|
C81.48 |
Lymphocyte-rich Hodgkin lymphoma,
lymph nodes of multiple sites |
|
C81.49 |
Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites |
|
C81.71 |
Other Hodgkin lymphoma, lymph
nodes of head, face, and neck |
|
C81.72 |
Other Hodgkin lymphoma,
intrathoracic lymph nodes |
|
C81.73 |
Other Hodgkin lymphoma,
intra-abdominal lymph nodes |
|
C81.74 |
Other Hodgkin lymphoma, lymph
nodes of axilla and upper limb |
|
C81.75 |
Other Hodgkin lymphoma, lymph
nodes of inguinal region and lower limb |
|
C81.76 |
Other Hodgkin lymphoma,
intrapelvic lymph nodes |
|
C81.77 |
Other Hodgkin lymphoma, spleen |
|
C81.78 |
Other Hodgkin lymphoma, lymph
nodes of multiple sites |
|
C81.79 |
Other Hodgkin lymphoma, extranodal and solid organ sites |
|
C81.91 |
Hodgkin lymphoma, unspecified,
lymph nodes of head, face, and neck |
|
C81.92 |
Hodgkin lymphoma, unspecified,
intrathoracic lymph nodes |
|
C81.93 |
Hodgkin lymphoma, unspecified,
intra-abdominal lymph nodes |
|
C81.94 |
Hodgkin lymphoma, unspecified,
lymph nodes of axilla and upper limb |
|
C81.95 |
Hodgkin lymphoma, unspecified,
lymph nodes of inguinal region and lower limb |
|
C81.96 |
Hodgkin lymphoma, unspecified,
intrapelvic lymph nodes |
|
C81.97 |
Hodgkin lymphoma, unspecified,
spleen |
|
C81.98 |
Hodgkin lymphoma, unspecified,
lymph nodes of multiple sites |
|
C81.99 |
Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
|
C82.01 |
Follicular lymphoma grade I, lymph
nodes of head, face, and neck |
|
C82.02 |
Follicular lymphoma grade I,
intrathoracic lymph nodes |
|
C82.03 |
Follicular lymphoma grade I,
intra-abdominal lymph nodes |
|
C82.04 |
Follicular lymphoma grade I, lymph
nodes of axilla and upper limb |
|
C82.05 |
Follicular lymphoma grade I, lymph
nodes of inguinal region and lower limb |
|
C82.06 |
Follicular lymphoma grade I,
intrapelvic lymph nodes |
|
C82.07 |
Follicular lymphoma grade I,
spleen |
|
C82.08 |
Follicular lymphoma grade I, lymph
nodes of multiple sites |
|
C82.09 |
Follicular lymphoma grade I, extranodal and solid organ sites |
|
C82.11 |
Follicular lymphoma grade II,
lymph nodes of head, face, and neck |
|
C82.12 |
Follicular lymphoma grade II,
intrathoracic lymph nodes |
|
C82.13 |
Follicular lymphoma grade II,
intra-abdominal lymph nodes |
|
C82.14 |
Follicular lymphoma grade II,
lymph nodes of axilla and upper limb |
|
C82.15 |
Follicular lymphoma grade II,
lymph nodes of inguinal region and lower limb |
|
C82.16 |
Follicular lymphoma grade II,
intrapelvic lymph nodes |
|
C82.17 |
Follicular lymphoma grade II,
spleen |
|
C82.18 |
Follicular lymphoma grade II,
lymph nodes of multiple sites |
|
C82.19 |
Follicular lymphoma grade II, extranodal and solid organ sites |
|
C82.21 |
Follicular lymphoma grade III,
unspecified, lymph nodes of head, face, and neck |
|
C82.22 |
Follicular lymphoma grade III,
unspecified, intrathoracic lymph nodes |
|
C82.23 |
Follicular lymphoma grade III,
unspecified, intra-abdominal lymph nodes |
|
C82.24 |
Follicular lymphoma grade III,
unspecified, lymph nodes of axilla and upper limb |
|
C82.25 |
Follicular lymphoma grade III,
unspecified, lymph nodes of inguinal region and lower limb |
|
C82.26 |
Follicular lymphoma grade III,
unspecified, intrapelvic lymph nodes |
|
C82.27 |
Follicular lymphoma grade III,
unspecified, spleen |
|
C82.28 |
Follicular lymphoma grade III,
unspecified, lymph nodes of multiple sites |
|
C82.29 |
Follicular lymphoma grade III,
unspecified, extranodal and solid organ sites |
|
C82.31 |
Follicular lymphoma grade IIIa,
lymph nodes of head, face, and neck |
|
C82.32 |
Follicular lymphoma grade IIIa,
intrathoracic lymph nodes |
|
C82.33 |
Follicular lymphoma grade IIIa,
intra-abdominal lymph nodes |
|
C82.34 |
Follicular lymphoma grade IIIa,
lymph nodes of axilla and upper limb |
|
C82.35 |
Follicular lymphoma grade IIIa,
lymph nodes of inguinal region and lower limb |
|
C82.36 |
Follicular lymphoma grade IIIa,
intrapelvic lymph nodes |
|
C82.37 |
Follicular lymphoma grade IIIa,
spleen |
|
C82.38 |
Follicular lymphoma grade IIIa,
lymph nodes of multiple sites |
|
C82.39 |
Follicular lymphoma grade IIIa, extranodal and solid organ sites |
|
C82.41 |
Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
|
C82.42 |
Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
|
C82.43 |
Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
|
C82.44 |
Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
|
C82.45 |
Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
|
C82.46 |
Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
|
C82.47 |
Follicular lymphoma grade IIIb, spleen |
|
C82.48 |
Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
|
C82.49 |
Follicular lymphoma grade IIIb, extranodal and solid
organ sites |
|
C82.51 |
Diffuse follicle center lymphoma,
lymph nodes of head, face, and neck |
|
C82.52 |
Diffuse follicle center lymphoma,
intrathoracic lymph nodes |
|
C82.53 |
Diffuse follicle center lymphoma,
intra-abdominal lymph nodes |
|
C82.54 |
Diffuse follicle center lymphoma,
lymph nodes of axilla and upper limb |
|
C82.55 |
Diffuse follicle center lymphoma,
lymph nodes of inguinal region and lower limb |
|
C82.56 |
Diffuse follicle center lymphoma,
intrapelvic lymph nodes |
|
C82.57 |
Diffuse follicle center lymphoma,
spleen |
|
C82.58 |
Diffuse follicle center lymphoma,
lymph nodes of multiple sites |
|
C82.59 |
Diffuse follicle center lymphoma, extranodal and solid organ sites |
|
C82.61 |
Cutaneous follicle center
lymphoma, lymph nodes of head, face, and neck |
|
C82.62 |
Cutaneous follicle center
lymphoma, intrathoracic lymph nodes |
|
C82.63 |
Cutaneous follicle center
lymphoma, intra-abdominal lymph nodes |
|
C82.64 |
Cutaneous follicle center
lymphoma, lymph nodes of axilla and upper limb |
|
C82.65 |
Cutaneous follicle center
lymphoma, lymph nodes of inguinal region and lower limb |
|
C82.66 |
Cutaneous follicle center lymphoma,
intrapelvic lymph nodes |
|
C82.67 |
Cutaneous follicle center
lymphoma, spleen |
|
C82.68 |
Cutaneous follicle center
lymphoma, lymph nodes of multiple sites |
|
C82.69 |
Cutaneous follicle center
lymphoma, extranodal and solid organ sites |
|
C82.81 |
Other types of follicular
lymphoma, lymph nodes of head, face, and neck |
|
C82.82 |
Other types of follicular
lymphoma, intrathoracic lymph nodes |
|
C82.83 |
Other types of follicular
lymphoma, intra-abdominal lymph nodes |
|
C82.84 |
Other types of follicular
lymphoma, lymph nodes of axilla and upper limb |
|
C82.85 |
Other types of follicular
lymphoma, lymph nodes of inguinal region and lower limb |
|
C82.86 |
Other types of follicular
lymphoma, intrapelvic lymph nodes |
|
C82.87 |
Other types of follicular lymphoma,
spleen |
|
C82.88 |
Other types of follicular
lymphoma, lymph nodes of multiple sites |
|
C82.89 |
Other types of follicular
lymphoma, extranodal and solid organ sites |
|
C82.91 |
Follicular lymphoma, unspecified,
lymph nodes of head, face, and neck |
|
C82.92 |
Follicular lymphoma, unspecified,
intrathoracic lymph nodes |
|
C82.93 |
Follicular lymphoma, unspecified,
intra-abdominal lymph nodes |
|
C82.94 |
Follicular lymphoma, unspecified,
lymph nodes of axilla and upper limb |
|
C82.95 |
Follicular lymphoma, unspecified,
lymph nodes of inguinal region and lower limb |
|
C82.96 |
Follicular lymphoma, unspecified,
intrapelvic lymph nodes |
|
C82.97 |
Follicular lymphoma, unspecified,
spleen |
|
C82.98 |
Follicular lymphoma, unspecified,
lymph nodes of multiple sites |
|
C82.99 |
Follicular lymphoma, unspecified, extranodal and solid organ sites |
|
C83.01 |
Small cell B-cell lymphoma, lymph
nodes of head, face, and neck |
|
C83.02 |
Small cell B-cell lymphoma,
intrathoracic lymph nodes |
|
C83.03 |
Small cell B-cell lymphoma,
intra-abdominal lymph nodes |
|
C83.04 |
Small cell B-cell lymphoma, lymph
nodes of axilla and upper limb |
|
C83.05 |
Small cell B-cell lymphoma, lymph
nodes of inguinal region and lower limb |
|
C83.06 |
Small cell B-cell lymphoma,
intrapelvic lymph nodes |
|
C83.07 |
Small cell B-cell lymphoma, spleen |
|
C83.08 |
Small cell B-cell lymphoma, lymph
nodes of multiple sites |
|
C83.09 |
Small cell B-cell lymphoma, extranodal and solid organ sites |
|
C83.11 |
Mantle cell lymphoma, lymph nodes
of head, face, and neck |
|
C83.12 |
Mantle cell lymphoma,
intrathoracic lymph nodes |
|
C83.13 |
Mantle cell lymphoma,
intra-abdominal lymph nodes |
|
C83.14 |
Mantle cell lymphoma, lymph nodes
of axilla and upper limb |
|
C83.15 |
Mantle cell lymphoma, lymph nodes
of inguinal region and lower limb |
|
C83.16 |
Mantle cell lymphoma, intrapelvic
lymph nodes |
|
C83.17 |
Mantle cell lymphoma, spleen |
|
C83.18 |
Mantle cell lymphoma, lymph nodes
of multiple sites |
|
C83.19 |
Mantle cell lymphoma, extranodal and solid organ sites |
|
C83.31 |
Diffuse large B-cell lymphoma,
lymph nodes of head, face, and neck |
|
C83.32 |
Diffuse large B-cell lymphoma,
intrathoracic lymph nodes |
|
C83.33 |
Diffuse large B-cell lymphoma,
intra-abdominal lymph nodes |
|
C83.34 |
Diffuse large B-cell lymphoma,
lymph nodes of axilla and upper limb |
|
C83.35 |
Diffuse large B-cell lymphoma,
lymph nodes of inguinal region and lower limb |
|
C83.36 |
Diffuse large B-cell lymphoma,
intrapelvic lymph nodes |
|
C83.37 |
Diffuse large B-cell lymphoma,
spleen |
|
C83.38 |
Diffuse large B-cell lymphoma,
lymph nodes of multiple sites |
|
C83.39 |
Diffuse large B-cell lymphoma, extranodal and solid organ sites |
|
C83.51 |
Lymphoblastic (diffuse) lymphoma,
lymph nodes of head, face, and neck |
|
C83.52 |
Lymphoblastic (diffuse) lymphoma,
intrathoracic lymph nodes |
|
C83.53 |
Lymphoblastic (diffuse) lymphoma,
intra-abdominal lymph nodes |
|
C83.54 |
Lymphoblastic (diffuse) lymphoma,
lymph nodes of axilla and upper limb |
|
C83.55 |
Lymphoblastic (diffuse) lymphoma,
lymph nodes of inguinal region and lower limb |
|
C83.56 |
Lymphoblastic (diffuse) lymphoma,
intrapelvic lymph nodes |
|
C83.57 |
Lymphoblastic (diffuse) lymphoma,
spleen |
|
C83.58 |
Lymphoblastic (diffuse) lymphoma,
lymph nodes of multiple sites |
|
C83.59 |
Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
|
C83.71 |
Burkitt lymphoma, lymph nodes of
head, face, and neck |
|
C83.72 |
Burkitt lymphoma, intrathoracic
lymph nodes |
|
C83.73 |
Burkitt lymphoma, intra-abdominal
lymph nodes |
|
C83.74 |
Burkitt lymphoma, lymph nodes of
axilla and upper limb |
|
C83.75 |
Burkitt lymphoma, lymph nodes of
inguinal region and lower limb |
|
C83.76 |
Burkitt lymphoma, intrapelvic lymph
nodes |
|
C83.77 |
Burkitt lymphoma, spleen |
|
C83.78 |
Burkitt lymphoma, lymph nodes of
multiple sites |
|
C83.79 |
Burkitt lymphoma, extranodal and solid organ sites |
|
C83.81 |
Other non-follicular lymphoma,
lymph nodes of head, face, and neck |
|
C83.82 |
Other non-follicular lymphoma,
intrathoracic lymph nodes |
|
C83.83 |
Other non-follicular lymphoma,
intra-abdominal lymph nodes |
|
C83.84 |
Other non-follicular lymphoma,
lymph nodes of axilla and upper limb |
|
C83.85 |
Other non-follicular lymphoma,
lymph nodes of inguinal region and lower limb |
|
C83.86 |
Other non-follicular lymphoma,
intrapelvic lymph nodes |
|
C83.87 |
Other non-follicular lymphoma,
spleen |
|
C83.88 |
Other non-follicular lymphoma,
lymph nodes of multiple sites |
|
C83.89 |
Other non-follicular lymphoma, extranodal and solid organ sites |
|
C83.91 |
Non-follicular (diffuse) lymphoma,
unspecified, lymph nodes of head, face, and neck |
|
C83.92 |
Non-follicular (diffuse) lymphoma,
unspecified, intrathoracic lymph nodes |
|
C83.93 |
Non-follicular (diffuse) lymphoma,
unspecified, intra-abdominal lymph nodes |
|
C83.94 |
Non-follicular (diffuse) lymphoma,
unspecified, lymph nodes of axilla and upper limb |
|
C83.95 |
Non-follicular (diffuse) lymphoma,
unspecified, lymph nodes of inguinal region and lower limb |
|
C83.96 |
Non-follicular (diffuse) lymphoma,
unspecified, intrapelvic lymph nodes |
|
C83.97 |
Non-follicular (diffuse) lymphoma,
unspecified, spleen |
|
C83.98 |
Non-follicular (diffuse) lymphoma,
unspecified, lymph nodes of multiple sites |
|
C83.99 |
Non-follicular (diffuse) lymphoma,
unspecified, extranodal and solid organ sites |
|
C84.01 |
Mycosis fungoides, lymph nodes of
head, face, and neck |
|
C84.02 |
Mycosis fungoides, intrathoracic
lymph nodes |
|
C84.03 |
Mycosis fungoides, intra-abdominal
lymph nodes |
|
C84.04 |
Mycosis fungoides, lymph nodes of
axilla and upper limb |
|
C84.05 |
Mycosis fungoides, lymph nodes of
inguinal region and lower limb |
|
C84.06 |
Mycosis fungoides, intrapelvic
lymph nodes |
|
C84.07 |
Mycosis fungoides, spleen |
|
C84.08 |
Mycosis fungoides, lymph nodes of
multiple sites |
|
C84.09 |
Mycosis fungoides, extranodal and solid organ sites |
|
C84.11 |
Sezary disease, lymph nodes of head, face, and neck |
|
C84.12 |
Sezary disease, intrathoracic lymph nodes |
|
C84.13 |
Sezary disease, intra-abdominal lymph nodes |
|
C84.14 |
Sezary disease, lymph nodes of axilla and upper limb |
|
C84.15 |
Sezary disease, lymph nodes of inguinal region and lower limb |
|
C84.16 |
Sezary disease, intrapelvic lymph nodes |
|
C84.17 |
Sezary disease, spleen |
|
C84.18 |
Sezary disease, lymph nodes of multiple sites |
|
C84.19 |
Sezary disease, extranodal and solid
organ sites |
|
C84.41 |
Peripheral T-cell lymphoma, not
classified, lymph nodes of head, face, and neck |
|
C84.42 |
Peripheral T-cell lymphoma, not
classified, intrathoracic lymph nodes |
|
C84.43 |
Peripheral T-cell lymphoma, not
classified, intra-abdominal lymph nodes |
|
C84.44 |
Peripheral T-cell lymphoma, not
classified, lymph nodes of axilla and upper limb |
|
C84.45 |
Peripheral T-cell lymphoma, not
classified, lymph nodes of inguinal region and lower limb |
|
C84.46 |
Peripheral T-cell lymphoma, not
classified, intrapelvic lymph nodes |
|
C84.47 |
Peripheral T-cell lymphoma, not
classified, spleen |
|
C84.48 |
Peripheral T-cell lymphoma, not
classified, lymph nodes of multiple sites |
|
C84.49 |
Peripheral T-cell lymphoma, not
classified, extranodal and solid organ sites |
|
C84.61 |
Anaplastic large cell lymphoma,
ALK-positive, lymph nodes of head, face, and neck |
|
C84.62 |
Anaplastic large cell lymphoma,
ALK-positive, intrathoracic lymph nodes |
|
C84.63 |
Anaplastic large cell lymphoma,
ALK-positive, intra-abdominal lymph nodes |
|
C84.64 |
Anaplastic large cell lymphoma,
ALK-positive, lymph nodes of axilla and upper limb |
|
C84.65 |
Anaplastic large cell lymphoma,
ALK-positive, lymph nodes of inguinal region and lower limb |
|
C84.66 |
Anaplastic large cell lymphoma,
ALK-positive, intrapelvic lymph nodes |
|
C84.67 |
Anaplastic large cell lymphoma,
ALK-positive, spleen |
|
C84.68 |
Anaplastic large cell lymphoma,
ALK-positive, lymph nodes of multiple sites |
|
C84.69 |
Anaplastic large cell lymphoma,
ALK-positive, extranodal and solid organ sites |
|
C84.71 |
Anaplastic large cell lymphoma,
ALK-negative, lymph nodes of head, face, and neck |
|
C84.72 |
Anaplastic large cell lymphoma,
ALK-negative, intrathoracic lymph nodes |
|
C84.73 |
Anaplastic large cell lymphoma,
ALK-negative, intra-abdominal lymph nodes |
|
C84.74 |
Anaplastic large cell lymphoma,
ALK-negative, lymph nodes of axilla and upper limb |
|
C84.75 |
Anaplastic large cell lymphoma,
ALK-negative, lymph nodes of inguinal region and lower limb |
|
C84.76 |
Anaplastic large cell lymphoma,
ALK-negative, intrapelvic lymph nodes |
|
C84.77 |
Anaplastic large cell lymphoma,
ALK-negative, spleen |
|
C84.78 |
Anaplastic large cell lymphoma,
ALK-negative, lymph nodes of multiple sites |
|
C84.79 |
Anaplastic large cell lymphoma,
ALK-negative, extranodal and solid organ sites |
|
C84.91 |
Mature T/NK-cell lymphomas,
unspecified, lymph nodes of head, face, and neck |
|
C84.92 |
Mature T/NK-cell lymphomas,
unspecified, intrathoracic lymph nodes |
|
C84.93 |
Mature T/NK-cell lymphomas,
unspecified, intra-abdominal lymph nodes |
|
C84.94 |
Mature T/NK-cell lymphomas,
unspecified, lymph nodes of axilla and upper limb |
|
C84.95 |
Mature T/NK-cell lymphomas,
unspecified, lymph nodes of inguinal region and lower limb |
|
C84.96 |
Mature T/NK-cell lymphomas,
unspecified, intrapelvic lymph nodes |
|
C84.97 |
Mature T/NK-cell lymphomas,
unspecified, spleen |
|
C84.98 |
Mature T/NK-cell lymphomas,
unspecified, lymph nodes of multiple sites |
|
C84.99 |
Mature T/NK-cell lymphomas,
unspecified, extranodal and solid organ sites |
|
C84.A1 |
Cutaneous T-cell lymphoma,
unspecified lymph nodes of head, face, and neck |
|
C84.A2 |
Cutaneous T-cell lymphoma,
unspecified, intrathoracic lymph nodes |
|
C84.A3 |
Cutaneous T-cell lymphoma, unspecified,
intra-abdominal lymph nodes |
|
C84.A4 |
Cutaneous T-cell lymphoma,
unspecified, lymph nodes of axilla and upper limb |
|
C84.A5 |
Cutaneous T-cell lymphoma,
unspecified, lymph nodes of inguinal region and lower limb |
|
C84.A6 |
Cutaneous T-cell lymphoma,
unspecified, intrapelvic lymph nodes |
|
C84.A7 |
Cutaneous T-cell lymphoma,
unspecified, spleen |
|
C84.A8 |
Cutaneous T-cell lymphoma,
unspecified, lymph nodes of multiple sites |
|
C84.A9 |
Cutaneous T-cell lymphoma,
unspecified, extranodal and solid organ sites |
|
C84.Z1 |
Other mature T/NK-cell lymphomas,
lymph nodes of head, face, and neck |
|
C84.Z2 |
Other mature T/NK-cell lymphomas,
intrathoracic lymph nodes |
|
C84.Z3 |
Other mature T/NK-cell lymphomas,
intra-abdominal lymph nodes |
|
C84.Z4 |
Other mature T/NK-cell lymphomas,
lymph nodes of axilla and upper limb |
|
C84.Z5 |
Other mature T/NK-cell lymphomas,
lymph nodes of inguinal region and lower limb |
|
C84.Z6 |
Other mature T/NK-cell lymphomas,
intrapelvic lymph nodes |
|
C84.Z7 |
Other mature T/NK-cell lymphomas,
spleen |
|
C84.Z8 |
Other mature T/NK-cell lymphomas,
lymph nodes of multiple sites |
|
C84.Z9 |
Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
|
C85.11 |
Unspecified B-cell lymphoma, lymph
nodes of head, face, and neck |
|
C85.12 |
Unspecified B-cell lymphoma,
intrathoracic lymph nodes |
|
C85.13 |
Unspecified B-cell lymphoma,
intra-abdominal lymph nodes |
|
C85.14 |
Unspecified B-cell lymphoma, lymph
nodes of axilla and upper limb |
|
C85.15 |
Unspecified B-cell lymphoma, lymph
nodes of inguinal region and lower limb |
|
C85.16 |
Unspecified B-cell lymphoma,
intrapelvic lymph nodes |
|
C85.17 |
Unspecified B-cell lymphoma,
spleen |
|
C85.18 |
Unspecified B-cell lymphoma, lymph
nodes of multiple sites |
|
C85.19 |
Unspecified B-cell lymphoma, extranodal and solid organ sites |
|
C85.21 |
Mediastinal (thymic) large B-cell
lymphoma, lymph nodes of head, face, and neck |
|
C85.22 |
Mediastinal (thymic) large B-cell
lymphoma, intrathoracic lymph nodes |
|
C85.23 |
Mediastinal (thymic) large B-cell
lymphoma, intra-abdominal lymph nodes |
|
C85.24 |
Mediastinal (thymic) large B-cell
lymphoma, lymph nodes of axilla and upper limb |
|
C85.25 |
Mediastinal (thymic) large B-cell
lymphoma, lymph nodes of inguinal region and lower limb |
|
C85.26 |
Mediastinal (thymic) large B-cell
lymphoma, intrapelvic lymph nodes |
|
C85.27 |
Mediastinal (thymic) large B-cell
lymphoma, spleen |
|
C85.28 |
Mediastinal (thymic) large B-cell
lymphoma, lymph nodes of multiple sites |
|
C85.29 |
Mediastinal (thymic) large B-cell
lymphoma, extranodal and solid organ sites |
|
C85.81 |
Other specified types of
non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
|
C85.82 |
Other specified types of
non-Hodgkin lymphoma, intrathoracic lymph nodes |
|
C85.83 |
Other specified types of
non-Hodgkin lymphoma, intra-abdominal lymph nodes |
|
C85.84 |
Other specified types of
non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
|
C85.85 |
Other specified types of
non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
|
C85.86 |
Other specified types of
non-Hodgkin lymphoma, intrapelvic lymph nodes |
|
C85.87 |
Other specified types of
non-Hodgkin lymphoma, spleen |
|
C85.88 |
Other specified types of
non-Hodgkin lymphoma, lymph nodes of multiple sites |
|
C85.89 |
Other specified types of
non-Hodgkin lymphoma, extranodal and solid organ
sites |
|
C85.91 |
Non-Hodgkin lymphoma, unspecified,
lymph nodes of head, face, and neck |
|
C85.92 |
Non-Hodgkin lymphoma, unspecified,
intrathoracic lymph nodes |
|
C85.93 |
Non-Hodgkin lymphoma, unspecified,
intra-abdominal lymph nodes |
|
C85.94 |
Non-Hodgkin lymphoma, unspecified,
lymph nodes of axilla and upper limb |
|
C85.95 |
Non-Hodgkin lymphoma, unspecified,
lymph nodes of inguinal region and lower limb |
|
C85.96 |
Non-Hodgkin lymphoma, unspecified,
intrapelvic lymph nodes |
|
C85.97 |
Non-Hodgkin lymphoma, unspecified,
spleen |
|
C85.98 |
Non-Hodgkin lymphoma, unspecified,
lymph nodes of multiple sites |
|
C85.99 |
Non-Hodgkin lymphoma, unspecified,
extranodal and solid organ sites |
|
C86.0 |
Extranodal NK/T-cell lymphoma, nasal type |
|
C86.1 |
Hepatosplenic T-cell lymphoma |
|
C86.2 |
Enteropathy-type (intestinal)
T-cell lymphoma |
|
C86.3 |
Subcutaneous panniculitis-like
T-cell lymphoma |
|
C86.4 |
Blastic NK-cell lymphoma |
|
C86.5 |
Angioimmunoblastic T-cell lymphoma |
|
C86.6 |
Primary cutaneous CD30-positive
T-cell proliferations |
|
C88.0 |
Waldenstrom macroglobulinemia (Lymphoplasmacytic lymphoma with
IgM-production) |
|
C88.2 |
Heavy chain disease |
|
C88.3 |
Immunoproliferative small
intestinal disease |
|
C88.4 |
Extranodal marginal zone B-cell lymphoma of mucosa-associated
lymphoid tissue [MALT-lymphoma] |
|
C88.8 |
Other malignant
immunoproliferative diseases |
|
C88.9 |
Malignant immunoproliferative
disease, unspecified |
|
C90.00 |
Multiple myeloma not having
achieved remission |
|
C90.01 |
Multiple myeloma in remission |
|
C90.02 |
Multiple myeloma in relapse |
|
C90.10 |
Plasma cell leukemia not having
achieved remission |
|
C90.11 |
Plasma cell leukemia in remission |
|
C90.12 |
Plasma cell leukemia in relapse |
|
C90.20 |
Extramedullary plasmacytoma not
having achieved remission |
|
C90.21 |
Extramedullary plasmacytoma in
remission |
|
C90.22 |
Extramedullary plasmacytoma in
relapse |
|
C90.30 |
Solitary plasmacytoma not having
achieved remission |
|
C90.31 |
Solitary plasmacytoma in remission |
|
C90.32 |
Solitary plasmacytoma in relapse |
|
C91.00 |
Acute lymphoblastic leukemia not
having achieved remission |
|
C91.01 |
Acute lymphoblastic leukemia, in
remission |
|
C91.02 |
Acute lymphoblastic leukemia, in
relapse |
|
C91.10 |
Chronic lymphocytic leukemia of
B-cell type not having achieved remission |
|
C91.11 |
Chronic lymphocytic leukemia of
B-cell type in remission |
|
C91.12 |
Chronic lymphocytic leukemia of
B-cell type in relapse |
|
C91.30 |
Prolymphocytic leukemia of B-cell
type not having achieved remission |
|
C91.31 |
Prolymphocytic leukemia of B-cell
type, in remission |
|
C91.32 |
Prolymphocytic leukemia of B-cell
type, in relapse |
|
C91.40 |
Hairy cell leukemia not having
achieved remission |
|
C91.41 |
Hairy cell leukemia, in remission |
|
C91.42 |
Hairy cell leukemia, in relapse |
|
C91.50 |
Adult T-cell lymphoma/leukemia
(HTLV-1-associated) not having achieved remission |
|
C91.51 |
Adult T-cell lymphoma/leukemia
(HTLV-1-associated), in remission |
|
C91.52 |
Adult T-cell lymphoma/leukemia
(HTLV-1-associated), in relapse |
|
C91.60 |
Prolymphocytic leukemia of T-cell
type not having achieved remission |
|
C91.61 |
Prolymphocytic leukemia of T-cell
type, in remission |
|
C91.62 |
Prolymphocytic leukemia of T-cell
type, in relapse |
|
C91.90 |
Lymphoid leukemia, unspecified not
having achieved remission |
|
C91.91 |
Lymphoid leukemia, unspecified, in
remission |
|
C91.92 |
Lymphoid leukemia, unspecified, in
relapse |
|
C91.A0 |
Mature B-cell leukemia
Burkitt-type not having achieved remission |
|
C91.A1 |
Mature B-cell leukemia
Burkitt-type, in remission |
|
C91.A2 |
Mature B-cell leukemia
Burkitt-type, in relapse |
|
C91.Z0 |
Other lymphoid leukemia not having
achieved remission |
|
C91.Z1 |
Other lymphoid leukemia, in
remission |
|
C91.Z2 |
Other lymphoid leukemia, in
relapse |
|
C92.00 |
Acute myeloblastic leukemia, not
having achieved remission |
|
C92.01 |
Acute myeloblastic leukemia, in
remission |
|
C92.02 |
Acute myeloblastic leukemia, in
relapse |
|
C92.10 |
Chronic myeloid leukemia,
BCR/ABL-positive, not having achieved remission |
|
C92.11 |
Chronic myeloid leukemia,
BCR/ABL-positive, in remission |
|
C92.12 |
Chronic myeloid leukemia,
BCR/ABL-positive, in relapse |
|
C92.20 |
Atypical chronic myeloid leukemia,
BCR/ABL-negative, not having achieved remission |
|
C92.21 |
Atypical chronic myeloid leukemia,
BCR/ABL-negative, in remission |
|
C92.22 |
Atypical chronic myeloid leukemia,
BCR/ABL-negative, in relapse |
|
C92.30 |
Myeloid sarcoma, not having
achieved remission |
|
C92.31 |
Myeloid sarcoma, in remission |
|
C92.32 |
Myeloid sarcoma, in relapse |
|
C92.40 |
Acute promyelocytic leukemia, not
having achieved remission |
|
C92.41 |
Acute promyelocytic leukemia, in
remission |
|
C92.42 |
Acute promyelocytic leukemia, in
relapse |
|
C92.50 |
Acute myelomonocytic leukemia, not
having achieved remission |
|
C92.51 |
Acute myelomonocytic leukemia, in
remission |
|
C92.52 |
Acute myelomonocytic leukemia, in
relapse |
|
C92.60 |
Acute myeloid leukemia with
11q23-abnormality not having achieved remission |
|
C92.61 |
Acute myeloid leukemia with
11q23-abnormality in remission |
|
C92.62 |
Acute myeloid leukemia with
11q23-abnormality in relapse |
|
C92.90 |
Myeloid leukemia, unspecified, not
having achieved remission |
|
C92.91 |
Myeloid leukemia, unspecified in
remission |
|
C92.92 |
Myeloid leukemia, unspecified in
relapse |
|
C92.A0 |
Acute myeloid leukemia with
multilineage dysplasia, not having achieved remission |
|
C92.A1 |
Acute myeloid leukemia with
multilineage dysplasia, in remission |
|
C92.A2 |
Acute myeloid leukemia with
multilineage dysplasia, in relapse |
|
C92.Z0 |
Other myeloid leukemia not having
achieved remission |
|
C92.Z1 |
Other myeloid leukemia, in
remission |
|
C92.Z2 |
Other myeloid leukemia, in relapse |
|
C93.00 |
Acute monoblastic/monocytic
leukemia, not having achieved remission |
|
C93.01 |
Acute monoblastic/monocytic
leukemia, in remission |
|
C93.02 |
Acute monoblastic/monocytic
leukemia, in relapse |
|
C93.10 |
Chronic myelomonocytic leukemia
not having achieved remission |
|
C93.11 |
Chronic myelomonocytic leukemia,
in remission |
|
C93.12 |
Chronic myelomonocytic leukemia,
in relapse |
|
C93.30 |
Juvenile myelomonocytic leukemia,
not having achieved remission |
|
C93.31 |
Juvenile myelomonocytic leukemia,
in remission |
|
C93.32 |
Juvenile myelomonocytic leukemia,
in relapse |
|
C93.90 |
Monocytic leukemia, unspecified,
not having achieved remission |
|
C93.91 |
Monocytic leukemia, unspecified in
remission |
|
C93.92 |
Monocytic leukemia, unspecified in
relapse |
|
C93.Z0 |
Other monocytic leukemia, not
having achieved remission |
|
C93.Z1 |
Other monocytic leukemia, in
remission |
|
C93.Z2 |
Other monocytic leukemia, in
relapse |
|
C94.00 |
Acute erythroid leukemia, not
having achieved remission |
|
C94.01 |
Acute erythroid leukemia, in
remission |
|
C94.02 |
Acute erythroid leukemia, in
relapse |
|
C94.20 |
Acute megakaryoblastic
leukemia not having achieved remission |
|
C94.21 |
Acute megakaryoblastic
leukemia, in remission |
|
C94.22 |
Acute megakaryoblastic
leukemia, in relapse |
|
C94.30 |
Mast cell leukemia not having
achieved remission |
|
C94.31 |
Mast cell leukemia, in remission |
|
C94.32 |
Mast cell leukemia, in relapse |
|
C94.40 |
Acute panmyelosis with myelofibrosis not having achieved
remission |
|
C94.41 |
Acute panmyelosis with myelofibrosis, in remission |
|
C94.42 |
Acute panmyelosis with myelofibrosis, in relapse |
|
C94.80 |
Other specified leukemias not
having achieved remission |
|
C94.81 |
Other specified leukemias, in
remission |
|
C94.82 |
Other specified leukemias, in
relapse |
|
C95.00 |
Acute leukemia of unspecified cell
type not having achieved remission |
|
C95.01 |
Acute leukemia of unspecified cell
type, in remission |
|
C95.02 |
Acute leukemia of unspecified cell
type, in relapse |
|
C95.10 |
Chronic leukemia of unspecified
cell type not having achieved remission |
|
C95.11 |
Chronic leukemia of unspecified
cell type, in remission |
|
C95.12 |
Chronic leukemia of unspecified
cell type, in relapse |
|
C95.90 |
Leukemia, unspecified not having
achieved remission |
|
C95.91 |
Leukemia, unspecified, in
remission |
|
C95.92 |
Leukemia, unspecified, in relapse |
|
C96.0 |
Multifocal and multisystemic
(disseminated) Langerhans-cell histiocytosis |
|
C96.21 |
Aggressive systemic mastocytosis |
|
C96.22 |
Mast cell sarcoma |
|
C96.29 |
Other malignant mast cell neoplasm |
|
C96.4 |
Sarcoma of dendritic cells
(accessory cells) |
|
C96.9 |
Malignant neoplasm of lymphoid,
hematopoietic and related tissue, unspecified |
|
C96.A |
Histiocytic sarcoma |
|
C96.Z |
Other specified malignant
neoplasms of lymphoid, hematopoietic and related tissue |
|
D37.01 |
Neoplasm of uncertain behavior of
lip |
|
D37.02 |
Neoplasm of uncertain behavior of
tongue |
|
D37.030 |
Neoplasm of uncertain behavior of
the parotid salivary glands |
|
D37.031 |
Neoplasm of uncertain behavior of
the sublingual salivary glands |
|
D37.032 |
Neoplasm of uncertain behavior of
the submandibular salivary glands |
|
D37.04 |
Neoplasm of uncertain behavior of
the minor salivary glands |
|
D37.05 |
Neoplasm of uncertain behavior of
pharynx |
|
D37.09 |
Neoplasm of uncertain behavior of
other specified sites of the oral cavity |
|
D37.1 |
Neoplasm of uncertain behavior of
stomach |
|
D37.2 |
Neoplasm of uncertain behavior of
small intestine |
|
D37.3 |
Neoplasm of uncertain behavior of
appendix |
|
D37.4 |
Neoplasm of uncertain behavior of
colon |
|
D37.5 |
Neoplasm of uncertain behavior of
rectum |
|
D37.6 |
Neoplasm of uncertain behavior of
liver, gallbladder and bile ducts |
|
D37.8 |
Neoplasm of uncertain behavior of
other specified digestive organs |
|
D38.0 |
Neoplasm of uncertain behavior of
larynx |
|
D38.1 |
Neoplasm of uncertain behavior of
trachea, bronchus and lung |
|
D38.2 |
Neoplasm of uncertain behavior of
pleura |
|
D38.3 |
Neoplasm of uncertain behavior of
mediastinum |
|
D38.4 |
Neoplasm of uncertain behavior of
thymus |
|
D38.5 |
Neoplasm of uncertain behavior of
other respiratory organs |
|
D39.0 |
Neoplasm of uncertain behavior of
uterus |
|
D39.11 |
Neoplasm of uncertain behavior of
right ovary |
|
D39.12 |
Neoplasm of uncertain behavior of
left ovary |
|
D39.2 |
Neoplasm of uncertain behavior of
placenta |
|
D39.8 |
Neoplasm of uncertain behavior of
other specified female genital organs |
|
D40.0 |
Neoplasm of uncertain behavior of
prostate |
|
D40.11 |
Neoplasm of uncertain behavior of
right testis |
|
D40.12 |
Neoplasm of uncertain behavior of
left testis |
|
D40.8 |
Neoplasm of uncertain behavior of
other specified male genital organs |
|
D41.01 |
Neoplasm of uncertain behavior of
right kidney |
|
D41.02 |
Neoplasm of uncertain behavior of
left kidney |
|
D41.11 |
Neoplasm of uncertain behavior of
right renal pelvis |
|
D41.12 |
Neoplasm of uncertain behavior of
left renal pelvis |
|
D41.21 |
Neoplasm of uncertain behavior of
right ureter |
|
D41.22 |
Neoplasm of uncertain behavior of
left ureter |
|
D41.3 |
Neoplasm of uncertain behavior of
urethra |
|
D41.4 |
Neoplasm of uncertain behavior of
bladder |
|
D41.8 |
Neoplasm of uncertain behavior of
other specified urinary organs |
|
D42.0 |
Neoplasm of uncertain behavior of
cerebral meninges |
|
D42.1 |
Neoplasm of uncertain behavior of
spinal meninges |
|
D43.0 |
Neoplasm of uncertain behavior of
brain, supratentorial |
|
D43.1 |
Neoplasm of uncertain behavior of
brain, infratentorial |
|
D43.3 |
Neoplasm of uncertain behavior of
cranial nerves |
|
D43.4 |
Neoplasm of uncertain behavior of
spinal cord |
|
D43.8 |
Neoplasm of uncertain behavior of
other specified parts of central nervous system |
|
D44.0 |
Neoplasm of uncertain behavior of
thyroid gland |
|
D44.11 |
Neoplasm of uncertain behavior of
right adrenal gland |
|
D44.12 |
Neoplasm of uncertain behavior of
left adrenal gland |
|
D44.2 |
Neoplasm of uncertain behavior of
parathyroid gland |
|
D44.3 |
Neoplasm of uncertain behavior of
pituitary gland |
|
D44.4 |
Neoplasm of uncertain behavior of craniopharyngeal duct |
|
D44.5 |
Neoplasm of uncertain behavior of
pineal gland |
|
D44.6 |
Neoplasm of uncertain behavior of
carotid body |
|
D44.7 |
Neoplasm of uncertain behavior of
aortic body and other paraganglia |
|
D45 |
Polycythemia vera |
|
D47.Z1 |
Post-transplant
lymphoproliferative disorder (PTLD) |
|
D47.Z2 |
Castleman disease |
|
D47.Z9 |
Other specified
neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
|
D48.0 |
Neoplasm of uncertain behavior of
bone and articular cartilage |
|
D48.1 |
Neoplasm of uncertain behavior of
connective and other soft tissue |
|
D48.2 |
Neoplasm of uncertain behavior of
peripheral nerves and autonomic nervous system |
|
D48.3 |
Neoplasm of uncertain behavior of
retroperitoneum |
|
D48.4 |
Neoplasm of uncertain behavior of
peritoneum |
|
D48.5 |
Neoplasm of uncertain behavior of
skin |
|
D48.61 |
Neoplasm of uncertain behavior of
right breast |
|
D48.62 |
Neoplasm of uncertain behavior of
left breast |
|
D48.7 |
Neoplasm of uncertain behavior of
other specified sites |
|
G13.0 |
Paraneoplastic neuromyopathy
and neuropathy |
|
R77.9 |
Abnormality of plasma protein,
unspecified |
|
R91.1 |
Solitary pulmonary nodule |
|
R91.8 |
Other nonspecific abnormal finding
of lung field |
|
R93.0 |
Abnormal findings on diagnostic
imaging of skull and head, not elsewhere classified |
|
R93.2 |
Abnormal findings on diagnostic
imaging of liver and biliary tract |
|
R93.3 |
Abnormal findings on diagnostic
imaging of other parts of digestive tract |
|
R93.5 |
Abnormal findings on diagnostic
imaging of other abdominal regions, including retroperitoneum |
|
R93.41 |
Abnormal radiologic findings on
diagnostic imaging of renal pelvis, ureter, or bladder |
|
R93.421 |
Abnormal radiologic findings on
diagnostic imaging of right kidney |
|
R93.422 |
Abnormal radiologic findings on
diagnostic imaging of left kidney |
|
R93.49 |
Abnormal radiologic findings on
diagnostic imaging of other urinary organs |
|
R94.02 |
Abnormal brain scan |
|
R97.21 |
Rising PSA following treatment for
malignant neoplasm of prostate |
|
|
NOTE: Whenever a personal history
diagnosis code (Z85.XXX) is on a claim, the claim must also contain a
diagnosis code from the list of covered C, D or R codes. |
|
Z85.01 |
Personal history of malignant
neoplasm of esophagus |
|
Z85.020 |
Personal history of malignant
carcinoid tumor of stomach |
|
Z85.028 |
Personal history of other
malignant neoplasm of stomach |
|
Z85.030 |
Personal history of malignant
carcinoid tumor of large intestine |
|
Z85.038 |
Personal history of other
malignant neoplasm of large intestine |
|
Z85.040 |
Personal history of malignant
carcinoid tumor of rectum |
|
Z85.048 |
Personal history of other
malignant neoplasm of rectum, rectosigmoid junction, and anus |
|
Z85.05 |
Personal history of malignant
neoplasm of liver |
|
Z85.060 |
Personal history of malignant
carcinoid tumor of small intestine |
|
Z85.068 |
Personal history of other
malignant neoplasm of small intestine |
|
Z85.07 |
Personal history of malignant
neoplasm of pancreas |
|
Z85.09 |
Personal history of malignant
neoplasm of other digestive organs |
|
Z85.110 |
Personal history of malignant
carcinoid tumor of bronchus and lung |
|
Z85.118 |
Personal history of other
malignant neoplasm of bronchus and lung |
|
Z85.12 |
Personal history of malignant
neoplasm of trachea |
|
Z85.21 |
Personal history of malignant neoplasm
of larynx |
|
Z85.22 |
Personal history of malignant
neoplasm of nasal cavities, middle ear, and accessory sinuses |
|
Z85.230 |
Personal history of malignant
carcinoid tumor of thymus |
|
Z85.238 |
Personal history of other
malignant neoplasm of thymus |
|
Z85.29 |
Personal history of other
malignant neoplasm of other respiratory and intrathoracic organs |
|
Z85.3 |
Personal history of malignant
neoplasm of breast |
|
Z85.41 |
Personal history of malignant
neoplasm of cervix uteri |
|
Z85.42 |
Personal history of malignant
neoplasm of other parts of uterus |
|
Z85.43 |
Personal history of malignant
neoplasm of ovary |
|
Z85.44 |
Personal history of malignant
neoplasm of other female genital organs |
|
Z85.46 |
Personal history of malignant
neoplasm of prostate:lll |
|
Z85.47 |
Personal history of malignant
neoplasm of testis |
|
Z85.48 |
Personal history of malignant
neoplasm of epididymis |
|
Z85.49 |
Personal history of malignant
neoplasm of other male genital organs |
|
Z85.51 |
Personal history of malignant
neoplasm of bladder |
|
Z85.520 |
Personal history of malignant
carcinoid tumor of kidney |
|
Z85.528 |
Personal history of other
malignant neoplasm of kidney |
|
Z85.53 |
Personal history of malignant
neoplasm of renal pelvis |
|
Z85.54 |
Personal history of malignant
neoplasm of ureter |
|
Z85.59 |
Personal history of malignant
neoplasm of other urinary tract organ |
|
Z85.6 |
Personal history of leukemia |
|
Z85.71 |
Personal history of Hodgkin
lymphoma |
|
Z85.72 |
Personal history of non-Hodgkin
lymphomas |
|
Z85.79 |
Personal history of other
malignant neoplasms of lymphoid, hematopoietic and related tissues |
|
Z85.810 |
Personal history of malignant
neoplasm of tongue |
|
Z85.818 |
Personal history of malignant
neoplasm of other sites of lip, oral cavity, and pharynx |
|
Z85.820 |
Personal history of malignant
melanoma of skin |
|
Z85.821 |
Personal history of Merkel cell
carcinoma |
|
Z85.828 |
Personal history of other
malignant neoplasm of skin |
|
Z85.830 |
Personal history of malignant
neoplasm of bone |
|
Z85.831 |
Personal history of malignant
neoplasm of soft tissue |
|
Z85.840 |
Personal history of malignant
neoplasm of eye |
|
Z85.841 |
Personal history ofmalignant neoplasm of brain |
|
Z85.848 |
Personal history of malignant
neoplasm of other parts of nervous system |
|
Z85.850 |
Personal history of malignant
neoplasm of thyroid |
|
Z85.858 |
Personal history of malignant
neoplasm of other endocrine glands |
|
Z85.89 |
Personal history of malignant
neoplasm of other organs and systems |